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Abstract 
The aim of the studies presented in this thesis was to develop a screen-printed 
electrochemical biosensor for the measurement of glutamate and to apply this device to the 
determination of the analyte in food, serum and toxicity studies.  
Chapter 1 serves as an introduction to both the physiological significance of glutamate and 
the fundamental principles underpinning the electrochemical techniques used throughout 
this thesis.  
Chapter 2 is a review chapter, separated into two main sections. The first section details 
glutamate biosensors fabricated with glutamate oxidase (GluOx), the second section details 
biosensors fabricated with glutamate dehydrogenase (GLDH). The immobilization 
techniques, ease of fabrication and sample preparation techniques employed are compared. 
Biosensor characteristics such as sensitivity, limit of detection and linear range are 
summarised within a table.  
The studies described in Chapter 3 focus on the development of a non-reagentless glutamate 
biosensor. A Meldola’s Blue screen-printed carbon electrode (MB-SPCE) was employed as 
the base transducer. The biosensor was constructed by drop coating the biopolymer chitosan 
(CHIT) and GLDH onto the surface of the MB-SPCE. For this study, NAD+ was present in 
free solution. Meldola’s Blue served as the electrocatalyst, whereby NADH produced by the 
GLDH/NAD+ reaction, was electrocatalytically oxidised at a low operating potential (+0.1V 
(vs. Ag/AgCl)). The applied potential, temperature, pH and concentration of the co-factors 
required for the biosensor operation were optimised in this study. The assay exhibited a 
linear range of 12.5 µM to 150 µM, limit of detection of 1.5 µM, response time of 2s and a 
sensitivity of 0.44 nA/ µM. The optimised biosensor was subsequently applied to the 
determination of endogenous and fortified concentrations of glutamate in both serum and 
food samples (OXO cubes). The serum was fortified with and the resulting mean recovery 
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was 96% with a CV of 3.3% (n = 6). For the food sample, an unfiltered beef OXO cube was 
analysed for monosodium glutamate (MSG) content. The endogenous content of MSG was 
125.43 mg/g, with a CV of 8.98% (n = 6). The solution was fortified with 100mM of 
glutamate and a resulting mean recovery of 91% with a CV of 6.39% (n = 6) was 
determined. 
In Chapter 4, the glutamate biosensor was further developed in order to produce a 
reagentless device whereby the cofactor NAD+ and GLDH were immobilized on to the 
surface of the electrode utilising CHIT. The reagentless device was developed in order to 
monitor glutamate release from human liver carcinoma cells (HepG2) as a result of cell 
toxicity from exposure to paracetamol. The biosensor was miniaturised in the form of a 
microband biosensor, whereby one dimension of the electrode is of micrometre size and the 
other millimetre size. Micro bands exhibit unique diffusion properties in comparison to 
conventional sized electrodes. Calibration studies were carried out with an applied potential 
of +0.1V (vs. Ag/AgCl) using both phosphate buffer and cell media. In phosphate buffer the 
following microband biosensor characteristics were determined: linear range; 25 - 125µM, 
sensitivity; 0.0636 nA/µM and a theoretical limit of detection of 1.20µM. In cell media; 
linear range; 25 – 150 µM, sensitivity; 0.128 nA/µM and a theoretical limit of detection of 
4.2µM. As the HepG2 cells were grown in an incubator at a fixed temperature and pH, 
studies were carried out at pH 7, 37ºC, in a 5% CO2 atmosphere. The miniaturised biosensor 
was applied to the determination of glutamate and the quantification was done by standard 
addition in cell media after 24 hours exposure to various concentrations of paracetamol. The 
average endogenous concentrations for glutamate released from the HepG2 cells was 
52.07µM (CoV: 13.74%, n = 3), 93.30µM (CoV: 18.41%, n = 3) and 177.14µM (CoV: 
14.54% n = 3) for 1mM, 5mM, 10mM doses of paracetamol respectively. The microband 
biosensor was also applied to the real time monitoring of glutamate over 8 hours. The 
standard deviations for the final current generated after eight hours are as follows; 1mM 
(coefficient of variation (CoV): 3.3%), 5mM (CoV: 9.056%) and 10mM (CoV: 13.18%). 
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The study showed that the magnitudes of the steady state currents increased in proportion to 
the concentration of added paracetamol. The study also demonstrated the possibility of 
applying microband biosensors, over extended time periods, for toxicity studies; there is no 
significant removal of analyte owning to the small biosensor dimensions. 
Chapter 5 describes the development of a reagentless conventional sized glutamate 
biosensor whereby the cofactor NAD+ and GLDH were immobilized using a combination of 
multi-walled carbon nanotubes (MWCNT), CHIT and additional water based MB in a 
layer-by-layer fashion. The MWCNT/CHIT/MB combination facilitates electron transfer to 
the surface of working electrode. The MWCNT/CHIT also entraps GLDH and the NAD+ on 
the surface of the electrode. The pH, temperature, optimum applied potential, 
concentrations of NAD+, CHIT and the addition of water-based MB were optimised. The 
electrocatalyst MB allowed a operating potential of +0.1V (vs. Ag/AgCl) to be utilised. The 
biosensor was examined with standard glutamate solutions and the following biosensor 
characteristics were determined; linear range; 7 - 105µM, LOD; 3 µM, sensitivity; 0.39 
nA/µM, response time 20-30s. A food sample was analysed for MSG and found to contain 
90.56 mg/g with a CV of 7.52% (n = 5). The reagentless biosensor was also applied to the 
determination of glutamate in serum. The endogenous concentration was found to be 
1.44mM (n = 5), CV: 8.54%. The recovery of glutamate in fortified serum was 104% (n = 
5), CV of 2.91%. The results indicate that the new biosensor holds promise for food and 
biomedical studies. 
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1.1 Introduction 
1.1.1 Glutamate 
Glutamate is considered to be the primary neurotransmitter in the mammalian brain and 
facilitates normal brain function [1]. It is a non-essential endogenous excitatory amino acid 
that is synthesised in neurons, from precursors such as glutamine and 2-oxoglutarate. Along 
with aspartate and homocysteine, glutamate contributes to excitatory neurotransmission in 
the central nervous system (CNS), whilst its immediate precursor gamma-aminobutyric acid 
(GABA) acts as an endogenous inhibitory neurotransmitter [2]. Neurotoxicity, which causes 
damage to brain tissue, can induced by glutamate at high concentrations. The accumulation 
of high concentrations of glutamate leads to the over activation of NMDA and AMPA 
receptors [3], which may link it to a number of neurodegenerative disorders such as 
Parkinson’s disease, multiple sclerosis [4] and Alzheimer’s disease [5]. 
In cellular metabolism, glutamate also contributes to the urea cycle and tricarboxylic acid 
cycle (TCA)/Krebs cycle. It plays a vital role in the assimilation of NH4
+ [6]. Glutamate is 
synthesised from NH4
+ and alpha-ketoglutarate by glutamate dehydrogenase (GLDH). The 
process is a reversible reaction, whereby glutamate can also be converted to alpha-
ketoglutarate by oxidative deamination. The reaction can only occur in the presence of the 
coenzyme nicotine adenine dinucleotide (NAD+). The direction of the reaction is primarily 
dependent on the relative concentrations of glutamate, alpha-ketoglutarate, ammonia and the 
ratio of oxidized to reduced coenzymes.  
Intracellular glutamate levels outside of the brain are typically 2–5 mmol/L, whilst 
extracellular concentrations are ~0.05 mmol/L [7] and is present in high concentrations 
throughout the liver, brain, kidney and skeletal muscle [8]. Glutamate has a significant role 
in the disposal of ammonia, which is typically produced from the digestion of dietary amino 
acids, protein and the ammonia produced by intestinal tract bacteria. Glutamate can also 
dispose of ammonia by being converted to glutamine by glutamine synthase.  
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Due to glutamate’s ubiquity throughout the human body and its central metabolic role, it is 
an excellent biomarker for toxicity. Many pharmaceutical compounds act upon disease 
causing cells by inducing cytoxicity via apoptosis and/or necrosis. This results in a loss of 
cell membrane integrity leading to the release of its cell contents, which includes glutamate 
[9].  
1.1.2 Drug Development and Toxicology 
Toxicology and cellular toxicity tests aim to study the potential effects on the human body 
that may be induced upon exposure to a substance, in an effort to monitor for any associated 
health risks that may occur. The process in determining the toxicity of a compound prior to 
clinical usage requires extensive testing. The average cost of developing a pharmaceutical 
drug, from its initial development to marketing, is around $2.5 billion and can take up to ten 
years [10]. As a result measures to improve efficiency and reduce the cost of testing 
prospective compounds are of great interest to the pharmaceutical industry.  
Preclinical trials of a prospective drugs require in vivo testing. By utilising an animal model, 
the characterisation of the toxicity, pharmacokinetic action and the efficacy of a drug may 
be determined [11]. However, there are many arguments as to whether testing on animals is 
an effective or acceptable means of predicting potential human toxicology [12]. Much 
concern is also placed on the ethical impact of testing on animals.  
In vitro testing concerns the analysis of the effects of toxic compounds upon cellular 
metabolism, without requirement of an animal model. Current toxicological analytical 
techniques include ELISA kits, neutral red uptake [13] and comet tests [14]; however these 
analytical techniques are time consuming, expensive and require specialist equipment. 
These techniques do not offer real time analysis or the ability to monitor the ongoing 
toxicological effect that a drug may have on the cells. Thus, the development of a high 
throughput system for in vitro cellular toxicity based on human cells for drug discovery 
purposes is of great clinical interest. Current high throughput systems for in vitro drug 
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toxicity screening include CellTiterGlow, ToxiLight, lactate dehydrogenase assay, CyQuant 
and Trypan Blue assays. These assays evaluate the effects of the anti-metabolic effects by 
utilising luminescent assays, fluorescent assays, the ability for the cell to uptake a reagent or 
by monitoring the release of an enzyme [15]. 
The development of electrochemical biosensors in order to monitor the effects of 
toxicological challenge upon cells offers promising advantages over existing toxicological 
techniques. Biosensors offer specificity for biologically relevant analytes due to their 
utilisation of an enzyme as part of their sensing system [16].  
1.1.3 HepG2  
The in vitro toxicity tests described later in the thesis utilise HepG2 as the cell culture 
model. HepG2 cells are immortalized human liver carcinoma cells. This cell line has been 
previously used to determine the cytotoxicity of compounds [17]–[20]. Indicators of HepG2 
cytotoxicity include glucose secretion, LDH leakage and elevated levels of gamma-glutamyl 
transferase [18]. The HepG2 cell line expresses many of the enzymes associated with 
cytochrome (CYP), in particular, phase I and phase II metabolic enzymes [21], [22].  
HepG2 cells may also be cultured into 3D aggregates known as spheroids, which behave 
like “mini-livers”. However, the drug toxicity interactions for 3D HepG2 cells are less 
established than monolayer interactions. In addition, other difficulties such as increased 
culturing complexity, significantly slower maturation of the cell line and inability to 
accurately count the number of cells due to aggregation may arise [23]. Thus, based on 
current in vitro toxicological methods currently utilised by pharmaceutical compounds, 3D-
cells lines are currently unsuited.  
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1.2 Biosensor Principles and Applications  
The first biosensor concept was proposed by Clark and Lyons from the Children Hospital in 
Cincinnati in 1962 [24]. The biosensor measured the depletion of oxygen generated by the 
oxidation of glucose in a thin layer of glucose oxidase over the gas permeable membrane of 
the sensor. The glucose oxidase biosensor has been developed enormously since its initial 
conception [25]. The analysis of glucose is considered vital to the management of blood 
glucose levels in diabetic patients [26] by the use of small glucose meters. The meters, both 
in the size and ease of use, have progressed vastly since the 1970’s, with particular 
breakthroughs occurring in the 1990’s, with the reduction in the volume of blood required to 
take a measurement and an increase in the accuracy in both high and low concentrations of 
glucose [27]. 
A biosensor is a chemical sensing device that relies on two basic components connected in 
series – a biochemical mechanism recognition system and a physio-chemical transducer. 
These provide a mean to convert chemical information such as the concentration of a 
sample into a useful signal which can be analysed [28]. The biological component of a 
biosensor can be split into two classifications; catalytic and non-catalytic. Catalytic 
components consist of micro-organisms, tissues and enzymes, whilst non-catalytic 
components comprise of antibodies, receptors and nucleic acids.  
The transduction technique will be dependent on the biological component in use. Examples 
of transduction techniques include: 
 Potentiometric – The measurement of the potential at zero current. The potential is 
proportional to the logarithm of the concentration of the substance being determined. 
 Voltammetric – Increasing or decrease the potential that is applied to a cell until the 
oxidation or reduction of the analyte occurs. This generates a rise in current that is 
proportional to the concentration of the electroactive potential. Once the desired stable 
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oxidation/reduction potential is known, stepping the potential directly to that value and 
observing the current is known as amperometry.   
 Conductiometric – Observing changes in electrical conductivity of the solution. [29] 
The most commonly used type of biosensor both in commercial production and research are 
enzyme based systems, coupled with amperometric transduction. Biosensors such as those 
produced by Clark and Lyons are described as being “first generation” devices. The 
generation was originally denoted to describe the level at which the biosensor was 
integrated. “First generation” biosensors are devices where the signals generated from the 
detection of the analyte of interest are as a result of membrane entrapped or bound 
biocomponents. “Second generation” biosensors entrap the biocomponents onto the surface 
of the electrode, as a result direct electron transfer occurs between the  enzyme active 
surface and transducer surface, shuttled by the mediator. “Third generation” biosensors 
differ from “second generation” biosensors by the lack of mediator required as direct 
electron transfer between the electrode surface and the active site of the enzyme occurs [30]. 
“Third generation” glucose biosensors have been developed [31], [32].  
 
 
 
 
 
 
 
Chapter One 
10 
 
1.2.1 Biosensor Fabrication 
Biosensors may be fabricated by the low cost method of screen printing. Other methods of 
fabrication such as ink-jet printing [33] and solid state technology [34] have been utilised to 
fabricate biosensors. Screen printing may be done by hand or by utilising an automated 
screen-printing machine.  
 
Figure 1-1. A diagram illustrating the screen-printing process. Used with permission 
from GEM.  
The principle of screen printing is the graphic reproduction of an image by use of ink or 
other viscous compound which is deposited as a film of controlled pattern and thickness. To 
do so, the ink is squeezed using a squeegee through a mesh which is tightly stretched over a 
frame. The ink is then deposited onto a substrate to produce a screen-printed electrode, 
which can be utilised once dried. Typically, polyester, PVC or ceramic substrates are used. 
The screen printing process is illustrated in Figure 1-1.  
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Figure 1-2: Diagram of a Screen-Printed Carbon electrode with the working area 
defined by insulating tape. 
The electrodes are then cut out from the card using scissors. An insulating dielectric layer, 
comprising a nonconductive ink, may then be applied to the electrode to define the working 
area if necessary, as demonstrated in Figure 1-2. Ag/AgCl reference electrodes may be also 
be produced by screen-printing methods.   
1.3 Electrode Modification 
1.3.1 Electrocatalysts  
Commonly used working electrode materials include carbon, gold, mercury or platinum. 
The material should allow for the application of wide potential windows whilst exhibiting 
favourable redox behaviour and reproducible electron transfer, in order to effectively 
characterise the species of interest.  
However, these materials require the use of large over-potentials to oxidize or reduce the 
electroactive species of interest. The over potential is the potential difference between the 
half-reaction reduction potential and the potential at which the redox reaction is observed. 
This presents some difficulties when analysing complex solutions and real samples as other 
compounds may also be electrocatalytically active at or around a similar potential as the 
analyte of interest. As a result, this may produce undesired interferences which reduce the 
signal-to-noise ratio, selectivity and sensitivity of the biosensor. By modifying the working 
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electrode by incorporating an electrocatalyst such as Meldola’s Blue, the potential required 
to determine the electroactive species can be significantly lowered.  
Meldola’s Blue (8-dimethylamino-2,3-benzophenoxazine; designated MB) is an electron 
mediator that has been utilised as an electrocatalyst in numerous biosensors. MB increases 
the charge transfer between the analyte and the electrode. It also eliminates the interaction 
between the electrode and the analyte itself. This leads to a decrease in the formal potential 
required to be applied to the electrode to produce an analytical response and an increase in 
current density [35]. This also leads to a reduction in the likelihood of interferences directly 
interacting with the working electrode and being oxidised/reduced, leading to undesired 
amperometric signals. At high overpotentials, an increased likelihood of electrode fouling 
can occur. Use of MB can also increase sensitivity for the amperometric detection of NADH 
(Figure 1-3). Meldola’s Blue was first utilised as a histochemical demonstrator of 
dehydrogenase activity [36], however, due to its excellent electron mediating abilities, it 
was soon patented and utilised as an electrocatalyst for the coenzyme regeneration and 
detection of NADH [37]. 
 
Figure 1-3 illustrates the charge transfer mechanism during the electrocatalytic 
reduction of MB. The active form of the electrode is then electrochemically 
regenerated. 
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The use of the mediator led to a 500mV reduction in potential required to 
electrocatalytically oxidise NADH, in comparison to an unmodified electrode [38]. At an 
unmodified screen-printed carbon electrode (SPCE), the anodic peak potential for NADH 
occurs at +0.500mV; with a modified MB-SPCE, the NADH oxidation occurs at -50mV 
[39].  
In order to immobilise the Meldola’s Blue to the surface of the electrode, various strategies 
have been used. Silica coated with niobium oxide was used to immobilize MB on a 
modified carbon paste electrode with well-defined electrochemical responses for NADH 
[40]. Functionalized carbon nanotubes, combined with MB, to form a nanocomposite film, 
have been used to non-covalently bind MB onto the surface of a glassy carbon electrode to 
detect NADH [41]. This method leads to excellent sensor characteristics such as low signal-
to-noise, low detection limits and a wide linear range. Titanium phosphate was also used to 
immobilize Meldola’s Blue onto a silica gel surface and subsequently incorporated into a 
carbon paste electrode [42]. Such immobilization techniques are often complex and time 
consuming. By incorporating Meldola’s Blue into a screen-printed carbon electrode 
fabrication costs can be reduced due to the increased potential for mass production, thereby 
rendering it more suitable for commercial purposes. Incorporating the mediator within the 
ink allows for further modification of the electrode surface with biological components such 
as enzymes and/or cofactors.  
In addition to the determination of NADH, biological compounds such as glucose [43], 
lactate [44][45], ammonia [46], glutamate [47], ethanol [48], fructose [49] and ascorbic acid 
[50] have also been determined utilising Meldola’s Blue as a mediator in conjunction with a 
variety of different enzymes.  
The biosensor described in this thesis will utilise the enzyme glutamate dehydrogenase 
(GLDH) and the coenzyme NAD+ with a MB-SPCE to detect glutamate, by following the 
production and subsequent oxidation of the enzymatically generated NADH.  
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1.3.2 Biological Modification of Electrodes  
Biosensors function by the coupling of a molecular recognition component with a physio-
chemical detector in close proximity [51]. Enzymes are typically used due to their high 
specificity, robustness and ability to bind to the surface of the transducer. By reducing the 
distance between the active site of the enzyme and the transducer surface, an increase in the  
electron transfer efficiency occurs, and the target analyte analysis can facilitated [52]. This 
can be achieved by immobilizing enzymes on the surface of the transducer.  
Enzymes can be immobilized using a variety of techniques, however it is important to select 
the appropriate method in order to retain as much of the enzyme activity as possible. Factors 
influencing the performance of an immobilized enzyme include the micro-environment of 
the carrier, diffusion constraints and the physical structure of the carrier [53]. 
Immobilisation may also result in the increased stability of the enzyme, resulting in 
potentially longer storage or operational times.  
1.3.3 Immobilization Techniques  
1.3.3.1 Covalent Bonding 
Covalent bonding as an immobilization technique involves the formation of covalent bonds 
between the enzyme and the support matrix. Enzymes possess side chain amino acids such 
as aspartic acid, histidine and arginine and thus may bind to amino, thiol, carboxyl and 
phenolic groups present within the support matrix. Ideally, the groups associated with the 
binding must not be electrocatalytically active. Covalent bonds are extremely strong, but 
this approach suffers from the disadvantage of irreversibly altering the structure of the 
enzyme, thereby resulting in a loss of activity or its deactivation [54].   
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1.3.3.2 Entrapment 
Entrapment is the caging of an enzyme within a gel or fibre by covalent or non-covalent 
interactions. Initial work in the entrapment of enzymes investigated the entrapment of 
glucose oxidase within conducting polypyrroles. The method involved the application of a 
potential to the working electrode immersed in a solution containing the enzyme and 
monomer. The enzymes near the working electrode were entrapped as the polymer grew 
[55]. However, due to the formation of a dense matrix upon the surface of the electrode, less 
substrate can diffuse deep into the matrix to reach the electrode surface. The enzyme may 
also leak into the surrounding solution.  
1.3.3.3 Adsorption  
Adsorption of an enzyme results from weak non-specific physical interactions such as Van 
Der Waals forces, ionic interactions and hydrogen bonding between the enzyme protein and 
the binding matrix utilised [56]. Adsorption results in little to no conformational change of 
the enzyme which thereby retains its original activity.  The immobilization matrix employed 
is termed the “carrier”. It is worth noting that not every enzyme will be successfully 
immobilized with every carrier, so it is important that the appropriate carrier, with the 
relevant functional groups, is selected.  
Enzyme carriers can be divided into both organic and inorganic origin. Inorganic agents 
such as silica, silica gel, metal oxides and organic natural carriers such as chitin, chitosan, 
cellulose and alginate are often utilised as enzyme immobilization agents. In particular, 
chitosan has been utilised extensively throughout this thesis as the primary enzyme carrier.  
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1.3.3.3.1 Chitosan  
Chitosan is a derivative of chitin, which is one of the world’s most plentiful organic 
resources and is derived from the shells of crustaceans. It is a linear polyaminosaccharaide 
composed of randomly distributed β-(1,4)-linked D-glucosamine and N-acetyl-D-
glucosamine groups. Due to its structure, chitosan possesses useful chemical and biological 
properties. 
 
Figure 1-4 – Structure of Chitosan.  
Chitosan is soluble in aqueous acidic media at pH < 6.5. When dissolved, it bears a high 
positive charge on its amino groups. Chitosan has gel-forming properties as a result of its 
ability to adhere to negatively charged surfaces and aggregate polyanionic compounds. It 
also possesses properties such as excellent biocompability, nontoxicity and protein affinity 
[57].  
1.3.4 Enzymology 
1.3.4.1 Enzyme Function 
Enzymes are proteins which are highly selective catalysts. They function by lowering the 
activation energy required (which is often the rate limiting step) thereby increasing the rate 
of reaction, leading to an increase in both speed of formation, and quantity of the product. 
Enzymatic reactions are often much faster than that of un-catalysed reactions, however, due 
to their high specificity, the substrates of the reaction must conform to the catalytic 
requirements of the enzyme to function effectively. Some enzymes require non-protein 
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cofactors that allow them to increase their functionality or to function at all. Enzymes are 
not consumed during a chemical reaction nor do they alter the equilibrium of the reaction. 
The specificity of an enzyme is dictated by its structure, charge and 
hydrophilic/hydrophobic characteristics. The specificity of an enzyme can be broken down 
into four types; absolute, group, linkage and stereochemical specificity. Absolute specificity 
restricts the enzyme to catalysing a single reaction, whilst group specificity only allows the 
enzyme to catalyse a specific functional group. Linkage specificity allows the enzyme to 
catalyse a reaction dependent on the presence of a specific type of chemical bond, whilst 
stereochemical specificity requires the enzyme to act on a specific stereoisomer which is 
dictated by the chirality of the enzyme active site [58].  
The theories upon which the interactions of enzymes and substrates are based are known as 
the lock-and-key or induced fit hypothesis. The lock-and-key hypothesis, pictured in Figure 
1-5a), states that only a specific substrate can correctly fit the active site of the enzyme. The 
induced fit hypothesis, proposed by Koshland and pictured in Figure 1-5b), suggests that a 
specific substrate can cause a three dimensional change in the enzyme, aligning the enzyme 
and substrate leading to the formation of a substrate-enzyme complex and consequently 
generating a product [59]. 
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Figure 1-5: Schematic diagram of the a) lock and key model and (b) induced fit 
hypothesis. This illustrates substrate-active site interaction.  
In the context of biosensors, the specificity of an enzyme can be a useful tool in fabricating 
biosensors that are selective for particular molecules.  
1.3.4.2 Enzyme Kinetics 
Enzyme kinetics is the study of reactions that are catalysed by enzymes. Specifically it 
investigates the rate of the reaction and how this is affected by varying the conditions of the 
reaction. The kinetics of an enzyme can reveal its mode of action and potential methods of 
inhibition.  
Single substrate reactions are the simplest enzymatic conversions possible. As illustrated in 
Figure 1-5. The formation of an enzyme-substrate complex leads to an increase in the rate 
of reaction due to the lowering of the activation energy required for the reaction.  
Enzymatic reactions based on a single substrate obey the Michaelis-Menten model of 
enzyme kinetics. The rate of an enzyme-catalysed reaction is dependent on the 
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concentration of the substrate (S). Low concentrations of the substrate result in an initial 
rate that is proportional to the enzyme velocity (V0) resulting in the linear part of the 
Michaelis-Menten plot illustrated in Figure 1-6, therefore first-order kinetics apply. Once 
the substrate has occupied all available enzyme sites and is forming enzyme-substrate 
complexes in equilibrium, the Vmax has been reached, and zero-order kinetics apply [60].  
 
Figure 1-6: How the reaction rate is altered by the substrate concentration in the 
presence of constant enzyme concentration.  
 
Figure 1-7: Enzyme substrate catalysis pathway.  
Figure 1-7 describes the kinetic properties of many enzymes, whereby the enzyme (E), 
combines with S to form a ES complex, at a rate of dictated by the rate constant k1.
 The 
complex can then either 1) dissociate to E + S by k-1 or 2) form the product (P) by k2 [61].  
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The rate of formation and breakdown of ES is expressed as the following.  
Formation 𝐸𝑆 =  𝐾1[𝐸][𝑆] Equation 1 
Breakdown ES = (𝐾−1 + 𝐾2)[𝐸𝑆] Equation 2 
Assuming steady-state conditions, whereby the concentrations of [ES] remain constant due 
to the equal rate of formation and breakdown, regardless of if the concentrations of [S] and 
[P] are changing. This can be defined by the following equation:  
 [E][S] 
[𝐸𝑆]
=  
(𝐾−1 + 𝐾2)
𝐾1
 
Equation 3 
This reaction can be simplified to the following, to give the Michaelis-Menten constant.  
 
𝑘𝑀 =  
(𝐾−1 + 𝐾2)
𝐾1
 
Equation 4 
The kM substrate concentration at which half the enzyme active sites are filled. pH, 
temperature, the enzyme and the substrate may affect the kM.  
By deriving Equation 4 further, the Michaelis-Menten equation (Equation 5) describes the 
formation of a steady state enzyme-substrate complex. V0 is the reaction rate, Vmax is the 
maximum reaction rate, [S] is the substrate concentration and the KM is the Michaelis-
Menten constant. The enzymatic activity is measured as a function of substrate 
concentration. When [S] < Kmax, the reaction proceeds under first-order kinetics, whilst 
when [S] > km, the reaction obeys zero-order kinetics. Therefore, the substrate concentration 
that produces half of the maximum reaction rate is termed the KM
 which is equal to half the 
VMAX.  
 
𝑉 =  (
Vmax[S]
KM + [S]
) 
Equation 5 
Chapter One 
21 
 
It is worth noting that some enzymes, such as dehydrogenases, require the presence of a 
cofactor, therefore in addition to the kinetics regarding the formation of an enzyme-
substrate complex, the formation of an enzyme-cofactor complex (EC) must be also 
considered. Slow enzyme kinetics may arise if the cofactor concentration is not in excess of 
the enzyme concentration. By supplementing the mixture with an fixed excess 
concentration of the relevant cofactor, these issues can be overcome [62].  
1.3.5 Dehydrogenase Enzymes 
The enzyme utilised in this thesis to produce biosensors is glutamate dehydrogenase 
(GLDH). Dehydrogenases are a class of enzymes that oxidize a substrate by a reduction 
reaction. The reaction results in the transfer of one or more hydrides (H-) to an electron 
acceptor, such as NAD+. GLDH is a mitochondrial enzyme that is present in the liver, heart, 
muscle and kidneys. It is a hexameric enzyme composed of ~500 residues in the animal 
kingdom [63] and a molecular weight of 49.2kD [64]. The enzyme has a glutamate binding 
domain and two-coenzyme binding sites, one for NAD+/NAD(P)+ and one for ADP, NAD+ 
and NADH. It catalyses the conversion of the amino group present on glutamate into a 
ammonium ion, by oxidative deamination. The reaction is a multi-step processes. The first 
step begins with the dehydrogenation of the carbon-nitrogen bond which leads to a Schiff-
base intermediate; this is catalysed by glutamate dehydrogenase and the co-factor NAD+, 
which is reduced to NADH. The hydrolysis of the Schiff base leads to the formation of α-
ketoglutarate [65].  
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Figure 1-8 An example of a typical reversible dehydrogenase reaction. [66] 
1.3.6 Cofactors  
Cofactors can be either metals or coenzymes, whose primary function is to assist enzyme 
activity. Coenzymes are organic, non-protein molecules which assist in biological reactions 
but do not form a permanent bond to the enzyme structure.  
Dehydrogenase enzymes require the presence of a cofactor such as NAD+. During an 
oxidation sequence such as the one illustrated by the reverse reaction in Figure 1-8, NAD+ is 
reduced to NADH by the transfer of H+ from the substrate (eg: glutamate) to NAD+ and the 
exchange of a proton into the media [67]. Coenzymes are continuously consumed and 
recycled.  
NAD+ is a dinucleotide consisting of an adenine base and nicotinamide joined by a 
phosphate bond between two phosphate groups. Its primary function is to facilitate redox 
reactions and is found in two forms; NAD+ an oxidising agent and NADH a reducing agent.  
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1.4 Equipment utilised for electrochemical techniques 
1.4.1 Electrochemical Cell 
Typically electrochemical reactions take place in an electrochemical cell (Figure 1-9) which 
is made from quartz or glass, into which the sample solution is added. The sample solution 
must be of sufficient depth to cover the two or three electrodes utilised. Variables such as 
temperature can be controlled by utilising a water-jacket cell, which is connected to a 
thermostatically controlled water bath. Experiments such as amperometry require stirring, 
thus a magnetic stirrer bar can sit at the bottom of the solution, which is controlled by a 
magnetic stirrer that sits underneath the electrochemical cell. The stirrer geometry should 
allow for consistent stirring. 
 
Figure 1-9 Schematic Diagram of a voltammetric cell based on a three electrode 
system. CE: counter electrode, WE: Working electrode, RE: Reference electrode. This 
is an example of a three electrode uncovered cell. 
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1.4.2 Working Electrode (WE) 
The working electrode (WE) is the location at which the reaction of interest takes place. The 
working electrode must be made of a material that is stable in the electrolyte medium 
utilised during the experiment, eg: carbon. This is to ensure that the electrode does not 
corrode or become fouled, thereby altering the surface area, and to prevent other compounds 
reducing in the potential range of interest. Working electrodes should have high surface 
reproducibility with a uniform distribution of potential across the surface to prevent IR drop. 
The background current within the potential region of interest should be low. The cost, 
availability and toxicity of the material should also be considered.  
1.4.3 Reference Electrode  
A reference electrode acts as a half-cell which has a stable and accurately maintained 
potential which is used a reference for the measurement of voltage applied by the counter 
electrode (CE). It is potentiometric and thus has zero current flowing through it. The 
potentiostat compensates if a difference in voltage is detected between the AE and WE and 
adjusts the output accordingly until the difference is zero, this action is known as feedback 
[68]. An example of a commonly used reference electrode the silver-silver chloride 
(Ag/AgCl) which is frequently used with screen printed carbon electrodes [69]. For 
applications such as chromoamperometry where small currents are flowing for short time 
periods, two electrode systems may be used, where the counter electrode assumes the role of 
RE and WE. Since current flowing through the reference electrode may alter its stability 
over time [70], three electrode systems with a counter electrode are often utilised in 
experimental situations, and for amperometric applications over prolonged time periods.  
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1.4.4 Counter Electrode 
The function of the counter electrode (CE) is to complete the circuit by applying a voltage 
difference respectively to the WE, thereby allowing charge to flow. The CE is composed of 
an inert material such as carbon or platinum.  
1.4.5 Potentiostat  
The instrument used to control the potential difference applied across the electrochemical 
cell is called a potentiostat (Figure 1-10). A potentiostat adjusts the voltage difference 
between the anode and the cathode in order to maintain a constant working electrode 
potential [71]. A potential is applied to the working electrode, resulting in a flow of charge 
towards the counter electrode. A potential drop (iR) is caused by the electrolyte 
conductivity, the distance between the electrodes, the magnitude of the current and 
resistance across the electrode material. If the iR drop is uncompensated, the reaction will 
no longer operate at the desired potential, and the reaction may cease. The reference 
electrode monitors the potential at the working electrode and feeds the value back to the op-
amp. If a difference in potential is observed between the RE and WE, the potential applied 
to the CE is altered to compensate. A second op-amp is used as a current-voltage converter 
to measure the flow of current, with a resistor used to output the voltage per unit current.  
 
Figure 1-10 A simplified circuit diagram of a three-electrode potentiostat.  
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1.4.6 Fundamentals of Electrochemistry  
1.4.6.1 Faradaic currents  
The Faradaic current is the current that flows through an electrochemical cell that is 
generated by the change in oxidation state of the electroactive species occurring at the 
electrode surface, combined with the current contribution due to the charge transfer between 
the electrode and the background analyte present in solution. The faradaic current obeys 
Faraday’s law. 
1.4.6.2 Charging currents and the Electrical Double Layer  
The application of a potential to the electrode surface causes ions near the electrode surface 
to migrate towards or away from the electrode depending on the respective charge of the 
electrode and the ions. This forms an electrical double layer, comprised of the electrical 
charge at the surface of the electrode and the charge of the ions in the solution near the 
electrode. This double layer leads to the generation of a non-faradaic charging current.  
The electrical double layer is an array of charged particles and orientated dipoles. It is 
composed of two layers; the layer closest to the electrode is known as the inner Helmholtz 
plane (IHP) and the outer Helmholtz plane (OHP) (Figure 1-11). The planes were 
discovered by Hermann von Helmholtz in 1853. The IHP is composed of solvent molecules 
and specifically adsorbed ions, whilst the OHP represents the imagined outer layer closest 
to the electrode that passes through the centre of solvated ions, but is separated by the 
molecules at the IHP [35]. These layers are both held at the surface of the electrode. The 
behaviour of the interface between the electrode and the solution is similar to that of a 
capacitor. 
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Figure 1-11:  Schematic representation of the electrical double layer. Reproduced with 
permission from Wiley.  
Beyond the double layer, is a diffuse layer of scattered ions that extents into the bulk 
solution. These ions are ordered relative to the coulombic forces acting upon them and the 
random motion of the solution by thermal motion.  
The balance of the electrostatic forces on ions at the surface of the electrode, which are 
repelled or attracted dependent on their charge, is counterbalanced by the random motion of 
the diffuse layer. This causes a non-uniform distribution of ions near the electrode surface. 
As a result, the field strength of the potential applied to the electrode diminishes rapidly, 
thereby causing the double layer to be extremely thin at 10 – 20 nanometers in thickness 
[72], [73]. It is also essential to use a high electrolyte concentration, typically a 100 fold 
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greater than that of the analyte, as this concentrates the charge at the Helmholtz planes, 
therefore ensuring that diffusion  is the dominant mechanism for mass transport [74]. 
1.4.6.3 Mass Transport   
Mass transport occurs by three different modes:  
 Diffusion: The spontaneous movement of particles as a result of a concentration gradient. 
Regions of high concentration move to regions of low concentration until equilibrium is 
established.  
 Convection: The transport of particles to the electrode by an external mechanical energy 
such as stirring or flowing the solution, rotating or vibrating the electrode.  
 Migration: The movement of charged particles along an electrical field.  
1.5 Electro-analytical Techniques  
The electrochemical techniques employed in this thesis study the current response of a 
biosensor by applying a potential (E) to a working electrode and measuring the resulting 
changes in current. The currents resulting from the interaction between the biosensor and 
the analyte can be used to quantify the analyte concentration. The technique employed will 
vary depending on what aspects of the cell are controlled and which are being measured. 
Common techniques include amperometry, chronoamperometry, cyclic voltammetry and 
hydrodynamic voltammetry. These techniques differ in the type of potential waveform 
utilised, the time that the potential is applied and wherever the measurements are conducted 
in a quiescent or stirred (forced convection) solution. The fundamental principles of these 
techniques will be discussed in this section.  
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1.5.1 Stirred Solution Techniques  
Electrochemical techniques utilising forced convection obey Fick’s first law of diffusion. 
Fick’s first law describes the diffusional flux (J) in relation to the diffusion coefficient (D) 
and the concentration gradient (C(x)).  
𝐽(𝑥,𝑡) =  −𝐷
𝜕𝐶(𝑥, 𝑡)
𝜕𝑥
 
Equation 6 
1.5.1.1 Nernst Diffusion Layer 
At the surface of the electrode, a thin layer of stagnant solution known as the Nernst 
diffusion layer (δ) is formed. The equation for the Nernst diffusion layer is given below 
(Equation 7), whereby A is the electrode area, n represents the number of electrons, D is the 
diffusion layer constant and CB is the concentration in bulk solution.  
By deriving from Fick first law (Equation 6), an equation determining the relationship 
between the concentration gradient and diffusion flux within the δ.  Therefore, any further 
increase in current is dependent on concentration in the bulk solution (CB) [75]. The Nernst 
diffusion layer remains constant at a fixed stirring rate. The optimum applied potential is 
regarded as where the limiting current has been reached, resulting in no further increase in 
sensitivity.  At this optimum potential, the current is limited by the diffusion of the 
electroactive species to the electrode surface through the δ, in accordance with Equation 7.  
 
𝑖𝐿𝐼𝑀 =
𝑛𝐹𝐴𝐷𝐶𝐵
𝛅
 
Equation 7 
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1.5.1.2 Hydrodynamic Voltammetry 
Hydrodynamic techniques are employed to determine the optimum applied potential (Eapp) 
to achieve maximum sensitivity in fixed potential techniques. HDV is based on controlled 
convective mass transport which is achieved by stirring the solution or by rotating or 
vibrating of the electrode. Amperometry in stirred solution is the most commonly used 
HDV technique; however other techniques such as flow wall jet and rotating disc techniques 
are also used. The solution is stirred and the Eapp is increased in sequential steps (Figure 
1-12), until a current plateau is achieved (Figure 1-13). The steady state reached after each 
Eapp increase is plotted to determine the limiting current (iL) and therefore the optimum 
applied potential to be used for amperometric determinations. 
 
Figure 1-12 Typical electrode potential increases 
Figure 1-13  Corresponding current output from potential increases 
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1.5.1.3 Amperometry 
A fixed potential is applied to an electrode against a reference electrode (Figure 1-14) until a 
steady state current is generated. This is achieved more readily in a stirred solution due to 
the greater efficiency of mass transport. Stirring also ensures that the concentration gradient 
at the working electrode is constant. Once steady state is achieved, standard additions of the 
analyte of interest are added into the voltammetric cell. The additions result in increases in 
current, with each addition occurring after steady state has been achieved, the magnitude of 
the current is proportional to the concentration of the analyte, which in turn is proportional 
to the rate of the redox reaction at the working electrode surface. An example of a typical 
amperometric plot is shown in Figure 1-15. 
 
Figure 1-14: Current waveform for amperometric experiments.  
Figure 1-15: A typical amperometric plot in stirred solution. Arrows indicate 
additions of the target analyte. 
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1.5.2 Quiescent Solution Techniques  
In unstirred solutions, the diffusion layer (δ) is fixed.  The magnitude of the current 
generated is derived from Ficks second law, which describes the rate of change of 
concentration with time, which is described in Equation 8 [76]. 
 𝑑𝐶
𝑑𝑡
= 𝐷(
𝑑2𝐶
𝑑𝑥2
) 
Equation 8 
1.5.2.1 Cyclic Voltammetry  
Cyclic voltammetry is a commonly used and versatile potentiodynamic electroanalytical 
technique used to study redox systems, the reversibility of the reaction, the stoichiometry of 
a system and the diffusion coefficient of an analyte. These can be used to determine the 
electrochemical characteristics and identity of an unknown compound.  
 
Figure 1-16. Cyclic voltammetry input waveform.  
 
E final 
E initial 
Forward Scan Reverse Scan 
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Figure 1-17 Typical Cyclic Voltammogram response for a reversible redox couple. [77] 
Cyclic voltammograms are characterized by six important parameters. 
 The cathodic (Epc) and anodic (Epa) peak potentials 
 The cathodic (ipc) and anodic (ipa) peak currents 
 The cathodic half-peak potential (Ep/2) 
 The half wave potential (E1/2) 
Cyclic voltammetry linearly applies a triangular potential ramp to the working electrode at a 
defined scan rate (V/s)/(vt) until it has reached a set switching potential as shown in Figure 
1-16. Once the switching potential on the triangular excitation potential ramp is reached, it 
begins a scan in the reverse direction. During the potential sweep, the current is measured 
resulting from the potential applied. The resulting plot of current vs. potential is known as a 
cyclic voltammogram, as illustrated in Figure 1-17.  
 
ipc 
Epc Epa 
ipa 
Potential 
Current 
Scan Direction 
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The two peak currents (ipc/ipa) and two peak potentials (Epc/Epa) form the basis for the 
analysis of the cyclic voltammetric response to the analyte. The shape of the voltammogram 
is due to the concentration of the reactant (R) or product (P) at the electrode surface during 
the scan. Ideally, the scan begins at a potential of negligible current flow whereby the 
analyte is neither oxidized nor reduced. As the potential is ramped linearly, electron transfer 
between the electrode and the analyte in the solution begins to occur; this leads to an 
accumulation of product and a depletion of the reactant. The ramp increases in accordance 
to the Nernst Equation. 
The Nernst equation relates the reduction potential of the half cell (Eo) with respect to the 
ratio of the concentrations of oxidized/reduced species at the surface of the electrode. This 
equation allows us to calculate to cell potential for any concentration. The Nernst equation 
is given in equation 9.  
 
𝐸 = 𝐸0 ∓ 
𝑅𝑇
𝑛𝐹
𝑙𝑜𝑔10
[𝑂𝑥]
[𝑅𝑒𝑑]
 
Equation 9 
Whereby, E represents the half-cell reduction potential, E0 represents the standard half-cell 
reduction potential, R; the universal gas constant (8.314 J K-1 mol-1), T; absolute 
temperature, n; number of electrons, F; Faraday constant, number of coulombs per mole of 
electrons (9.x 104 C mol-1).  
At the peak of the anodic wave the reaction becomes diffusion controlled, as the diffusion 
layer has grown sufficiently from the electrode that the flux of the product to the electrode is 
too slow to satisfy the Nernst equation. As a result, the concentration of the reactant at the 
surface reaches zero. Subsequently, the rate of diffusion then decreases, reducing the current 
flow, in accordance with the Cottrell equation. Once the potential ramp has reached the 
switching potential, the potential is ramped in the opposite direction resulting in a cathodic 
potential being applied.   
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The peak current for a reversible system is described by the Randles-Sevcik equation [72]. 
The current is directly proportional to the concentration and increases in respect to the 
square root of the scan rate. This dependence on scan rate implies the reaction at the 
electrode is controlled by mass transport. The equation applies at standard temperatures. 
(25°C, n = number of electrons involved, A = electrode area, D = diffusion co-efficient, CB
 
= bulk electrode concentration and v = scan rate).  
 
𝑖𝑝 = (2.69 ∗ 105)𝑛
3
2𝐴𝐷
1
2𝐶𝐵𝑣
1
2 
Equation 10 
The reversibility of a electrochemically reversible couple can be identified by the 
measurement of the potential difference the two peak potentials. An electrochemically 
reversible system based on a one electron transfer process is denoted in equation  A fast one 
electron transfer exhibits a ∆Ep of 59mV.  
 
∆𝐸𝑝 = 𝐸𝑝𝑎 − 𝐸𝑝𝑐 =  
59
𝑛
𝑚𝑉 
Equation 11 
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1.5.2.2 Chronoamperometry 
Chronoamperometry differs from amperometry by being conducted in a quiescent, unstirred 
solution. A sufficient Eapp is applied to drive a redox reaction at the surface (Figure 1-18a); 
this generates a large current which decays rapidly as the concentration of the analyte is 
depleted at the electrode surface due to the diffusion (Figure 1-18b).  
The variation in the magnitude of current with time for a planar electrode is described by the 
Cottrell equation (Equation 12) [78], which is derived from Fick’s second law. The equation 
is described as follows; N represents the number of electrons, F is the Faraday constant, A is 
the electrode area (cm2), Co is the bulk electrolyte concentration (mol/cm3), t is time 
(seconds) and D is the diffusion coefficient (cm2/s) 
 
𝑖𝑡 =  
𝑛𝐹𝐴𝐶0𝐷
1
2
𝜋
1
2  𝑡
1
2
 
Equation 12 
a)  b)   
Figure 1-18 - a) excitation waveform b) current response output generated from the 
excitation waveform.  
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1.5.3 Electrochemical Behaviour using Miniaturized Electrodes 
In this section, a brief description of the types of voltammetric signals achieved at 
microelectrodes together with some important diagnostic equations to elucidate 
microelectrode behaviour will be discussed.  
Microelectrodes differ from traditional conventional sized macroelectrodes by possessing 
one dimension that does not exceed 25 micrometers [79]. Microelectrodes possess the 
following properties: high current densities, the generation of small currents (typically on 
the picoamp / nanoamp scale), fast establishment of steady state signals, resistance to ohmic 
drop and short response times [80].  
During short experimental timescales, for example, when conducting cyclic voltammetry 
with fast scan rates (>50 mV/s), planar diffusion occurs, thus the current will decay in 
accordance with the Cottrell equation (Equation 12). This only occurs in the short time in 
which the diffusion layer (δ), is smaller than the radius (r) of the electrode.  
During long experimental timescales, when δ > r, radial (nonplanar) diffusion dominates 
mass transport, thus under these conditions the current density becomes steady state as 
given by Equation 13, whereby r is the microelectrode radius, n is number of electrons in 
the reaction, D is the diffusion coefficient in cm2/s, C is the bulk concentration of the 
electroactive species in mol/cm3, and r is the radius of the microelectrode in cm.  
 
𝑖𝑑 =
𝑛𝐹𝐷𝑐∞
𝑟𝑠
 
Equation 13 
The steady state limiting current is directly proportional to the concentration of the analyte 
and the diffusion coefficient. Therefore, if the diffusion coefficient is known, the 
concentration of the analyte can also be calculated.  
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Figure 1-19: Radial diffusion at the surface of a microelectrode and the hemispherical 
shape of the diffusion layer extending out into the bulk solution. Arrows indicate the 
direction of diffusion to the electrode.  
Due to this increased flux to the surface, a concentration gradient between the electrode and 
the bulk solution occurs, known as the diffusion layer. At longer experimental time scales 
this diffusion layer exceeds the radius of the microelectrode, becoming a spherical diffusion 
field as illustrated in Figure 1-19. This increased flux, results in more efficient mass 
transport, leading to steady state responses and increased current densities.  
Subsequent studies discussed in the thesis are based on microband electrodes. These 
microelectrodes possess a different geometry to co-planar disc-shaped microelectrodes, thus 
Equation 14 will be applied to illustrate microband behaviour [81]. Microband electrodes 
possess an increased electrode area due to the 3mm length, whilst the width of the 
microelectrode is within the micrometre range, therefore radial diffusion is diffusion is 
dominant leading to microelectrode characteristics [82].  
 
𝑖𝐿𝐼𝑀 = 2𝜋𝐹𝐶𝐷𝑙 
1
ln(4𝐷𝑡𝜋/𝑊2)
 
Equation 14 
Radial diffusion, as illustrated in Figure 1-19, leads to higher current densities under steady-
state (time independent) conditions, as a result of the increased flux of electroactive species 
to the surface of the electrode. However, the diffusion that occurs at a microband electrode 
as shown in Figure 1-20, is not uniform, thus edge mass transport dominates [83]. 
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Figure 1-20: A schematic diagram of a microband electrode.  
Figure 1-21 illustrates a typical microelectrode voltammogram in a under state-state 
conditions in an electrochemically reversible system at a slow scan rate. Microelectrodes 
present voltammograms possessing a sigmoidal shape with no peaks, smaller current 
magnitudes and steady-state/constant currents. If the scan rate is increased planar diffusion 
occurs and typical cyclic voltammetric behaviour is observed.  
 
Figure 1-21: A typical cyclic voltammogram displaying microelectrode behaviour, at a 
slow scan rate. 
 
 
 
 
Chapter One 
40 
 
1.6 Aims and Objectives 
The aim of the work described in this thesis was to develop amperometric, screen printed 
glutamate biosensors and to apply these devices for the determination of glutamate in 
clinical and food studies, as well as to toxicity studies. For the latter the intention was to 
monitor, glutamate released by HepG2 cells in response to toxic challenge from 
paracetamol. The objectives were; 
 Development of a glutamate biosensor utilising glutamate dehydrogenase, NAD+ 
based on Meldola’s Blue screen printed carbon electrodes.  
 Immobilisation of the enzyme glutamate dehydrogenase to the surface of the 
working electrode the MB-SPCE to produce glutamate biosensors. 
 Optimisation of the biosensor working conditions and the determination of the 
glutamate content of food and clinical samples utilising standard addition.  
 Further development of the biosensor to immobilize the cofactor NAD+ onto the 
surface of the screen-printed carbon electrode.  
 The miniaturisation of the biosensor in order to develop microband biosensors for 
the determination of glutamate released by HepG2 cells in response to toxic challenge.  
 Development of an electrode holder to simultaneously immerse the biosensor within 
the cell media solution for the interrogation of the cells, whilst reducing evaporation and 
allowing for gas exchange between the cell media and atmosphere.  
 Development of a conventional sized reagentless glutamate biosensor.  
 Optimisation of the biosensor components and working conditions, in order to apply 
the reagentless biosensor to the determination of glutamate in complex samples.  
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2.1 Introduction 
This review discusses electrochemical biosensors fabricated based on glutamate oxidase or 
glutamate dehydrogenase.  The  method of enzyme immobilization and, where applicable, 
the application of glutamate biosensors to biological and food samples.  
2.2 Biosensors based on glutamate oxidase 
In this section, the fabrication methods are sub-divided according to the technique of 
enzyme immobilization. The electrochemical response can generally be described by the 
following equations:  
       Glutamate   + O2
                        GluOx                  
H2O2 + α-ketoglutarate (1) 
                H2O2  
                                                              
2H
+
 + O2 + 2e
-
  (2) 
Equation 1 represents the enzymatic oxidation of the glutamate to form α-ketoglutarate and 
H2O2. Equation 2 describes the electrochemical detection of hydrogen peroxide at the base 
transducer which generates the analytical response.   
2.2.1 Entrapment 
The entrapment of enzymes is defined as the integration of an enzyme within the lattice of a 
polymer matrix or a membrane, whilst retaining the protein structure of the enzyme [10]. In 
addition to the immobilization of enzymes, membranes can also eliminate potential 
interfering species that may be present in complex media such as serum and food.  
A selective biosensor for the determination of glutamate in food seasoning was developed 
by incorporating glutamate oxidase into a poly(carbamoyl) sulfonate (PCS) hydrogel. The 
GluOx-PCS mixture was then drop-coated onto the surface of a thick-film platinum 
electrode [11]. Liquid samples (1, 10 and 100µL) were diluted to 10mL with phosphate 
buffer. The biosensor was then utilised to determine the glutamate recovery from different 
concentrations of the sample. The results generated correlated favourably with a L-
glutamate colorimetric test kit. 
Chapter Two 
55 
 
A recent application of a micro glutamate biosensor for investigating artificial cerebrospinal 
fluid (CSF) under hypoxic conditions was described [12].  The fabrication method is a 
complex, multi-step process whereby glutamate oxidase is incorporated with chitosan and 
ceria-titania nanoparticles (Figure 1). 
 
Figure 2-1: Schematic illustration of the biosensor design and the GluA detection 
principle. (Reprinted with permission from [12], Elsevier) 
The nanoparticles are able to store and release oxygen in its crystalline structure; it can 
supply O2 to GluOx to generate H2O2 in the absence of environmental oxygen. The 
biosensor was evaluated with artificial CSF which had been fortified with glutamate over 
the physiological range; the device was found to operate over the concentration of interest 
under anaerobic conditions. 
A device for the measurement of glutamate in brain extracellular fluid utilising a relatively 
simple fabrication procedure has been reported [13]. The procedure involved dipping a 60-
µm radius Teflon coated platinum wire into a buffered solution containing glutamate 
oxidase and o-phenylenediamine (PPD), followed by a solution containing 
phosphatidylethanolamine (PEA) and bovine serum albumin (BSA). The glutamate oxidase 
was entrapped by the electropolymerization of PPD on the surface of the electrode. The 
PPD and PEA was used to block out interferences.  
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An interesting entrapment approach employing polymers to encapsulate GluOx onto a gold 
electrode has been reported [14]. The first step involved the immersion of a gold disc 
electrode in 3-mercaptopropionic acid (MPA) solution, followed by drop-coating layers of 
poly-L-lysine and poly(4-styrenesulfonate). Once dry, a mixture of GluOx and 
glutaraldehyde was drop-coated on to the surface to form a bilayer. The authors suggested 
that MPA increases the adhesion of the polyion complex to the gold surface by the 
electrostatic interaction between the carboxyl groups present on the MPA and the amino 
groups present on the poly-L-lysine. A response time of only 3 seconds was achieved after 
an addition of 20nM glutamic acid, which gave a current of 0.037 nA (1.85 nA/µM). A 
linear response was observed between 20µM and 200µM. Both the response time and limit 
of detection are superior to previously discussed biosensors. It was suggested that the rapid 
response was due to the close proximity of the enzymatic reaction to the surface of the 
electrode. For this method of fabrication of glutamate oxidase based biosensors, the latter 
approach leads to the lowest limit of detection.  
The increased interest in glutamate measurement has led to the commercial development of 
an in vivo glutamate biosensor by Pinnacle Technology Inc. [15]; this has been successfully 
used for  monitoring of real-time changes of glutamate concentrations in rodent brain. The 
biosensor employs an enzyme layer composed of GluOx and an “inner-selective” 
membrane, composed of an undisclosed material that eliminates interferences. The 
enzymatically generated hydrogen peroxide is monitored using a platinum-iridium 
electrode. The biosensor possesses a linear-range up to 50µM. The manufacturers indicate 
that the miniaturised biosensor requires calibration upon completion of an experiment in 
order to ensure the selectivity and integrity of the sensors.  
2.2.2 Covalent-bonding 
The application of a glutamate oxidase based biosensor for the measurement of glutamate in 
the serum of healthy and epileptic patients has been described [16]. The fabrication method 
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consists of electrodepositing chitosan (CHIT), gold nanoparticles (AuNP) and multiwalled 
carbon nanotubes (MWCNTs) on the surface of a gold electrode.  
The serum sample was diluted with phosphate buffer solution (PBS) before analysis. The 
concentration of the glutamate in the sample was determined using a standard calibration 
curve constructed from the amperometric responses obtained with glutamate in PBS. The 
results compared favourably with a colorimetric test kit. A low operating potential of 
+0.135 V vs. Ag/AgCl for measuring the enzymatically generated H2O2 was significantly 
lower than other biosensors based on GluOx [13,17], The time taken to reach 95% of the 
maximum steady state response was 2 seconds after the initial injection. This method of 
fabrication whilst complex, possesses a significantly lower operating potential when 
compared to other biosensors fabricated using entrapment techniques.  
2.2.3 Cross-linking  
Enzyme immobilization can be achieved by intermolecular cross-linking of the protein 
structure of the enzyme to other protein molecules or within an insoluble support matrix. 
Jamal et. al. [17] have described a complex entrapment method which consisted of drop-
coating a 10µL mixture of GluOx (25U in 205µL), 2mg of BSA, 20µL of glutaraldehyde 
(2.5% w/v) and 10µL of Nafion (0.5%) onto a platinum nanoparticle modified gold 
nanowire array (PtNP-NAE) and allowing it to dry overnight under ambient conditions. The 
fabrication technique is illustrated in Figure 2-2.  The analytical response results from the 
oxidation of H2O2 at the gold nanowire electrode as illustrated in Equation 2.   
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Figure 2-2: Schematic illustration of stepwise fabrication of the GlutOx/PtNP/NAEs 
electrodes. Reprinted with permission from [18], Elsevier. 
The high sensitivity obtained appears to be related to the presence of the nanoparticles at the 
gold electrode surface. The nanoparticles act as conduction centres and facilitate the transfer 
of electrons towards the gold electrode. Additionally, a high enzyme loading was utilised, 
which in combination with the nanoparticles, resulted in increased enzyme immobilisation 
to the surface. However, given the high enzyme loading and use of both a gold nanowire 
electrode and platinum nanoparticles, the biosensor is unlikely to be commercially viable 
due to its high cost.  
GluOx was immobilized to the surface of a palladium-electrodeposited screen printed 
carbon strip by a simple crosslinking immobilisation technique using a photo-crosslinkable 
polymer (PVA-SbQ) [18]. The biosensor exhibited a stable steady state response for six 
hours in a stirred solution indicating that the enzyme was fully retained within the polymer 
membrane.  
A glutamate biosensor [19] was successfully applied to the determination of MSG in soy 
sauce, tomato sauce, chicken thai soup and chilli chicken. MSG levels compared very 
favourably with a spectrophotometric method (2 - 5% CoV based on n = 5). The biosensor 
was fabricated by mixing glutamate oxidase, BSA and glutaraldehyde, then spreading the 
mixture onto the surface of an O2 permeable poly-carbonate membrane. The membrane was 
Chapter Two 
59 
 
then attached to an oxygen probe using a push cap system and oxygen consumption was 
measured at an applied potential of  -0.7 V; this is a considerably more negative operating 
potential compared to previously discussed biosensors. In this case, the response is a result 
of the reduction reaction shown in Equation 3.  
 O2 + 2e
- + 2H+                                     H2O2  (3) 
The lowest limit of detection achieved with a glutamate biosensor was fabricated by 
covalently immobilizing glutamate oxidase onto polypyrrole nanoparticles and polyaniline 
composite film (PPyNPs/PANI) [20]. Cyclic voltammetry was used to co-electropolymerize 
the compounds onto the surface. The PPyNPs act as an electron transfer mediator which 
allows a low operating potential to be employed (+85 mVs), that reduces the likelihood of 
oxidising interferences. The authors also claim that this leads to an increase in the 
sensitivity of the biosensor. The biosensor was successfully applied to the determination of 
glutamate in food samples including tomato soup and noodles. High recoveries of 95% - 
97% were achieved which compares favourably with values attained by previously 
discussed biosensors [19].  
2.3 Biosensors based on glutamate dehydrogenase 
This section is subdivided in a similar way to section 2, ie: according to the method of 
immobilization. The electrochemical response can generally be described by the following 
equations:  
      Glutamate  + NAD
+              GLDH              
NADH + α-ketoglutarate (4) 
      NADH  + Mediatorox
                                     
NAD
+
 + Mediatorred  (5) 
      Mediatorred
                                                             
ne
-
 + mH
+
 + Mediatorox  (6) 
Equation 4 represents the enzymatic reduction of the cofactor NAD+ to NADH and the 
oxidation of glutamate to α-ketoglutarate. Equation 5 represents the electrochemical 
reduction of the oxidised mediator to the reduced form (Mediatorred). Equation 6 describes 
the electrochemical oxidation of Mediatorred at the base transducer which generates the 
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analytical response; the regenerated mediator ox, can then undergo further reactions with 
NADH. Equations 4 and 5 represent the electrocatalytic oxidation of NADH, which occurs 
at lower applied potentials than obtained by the direct electrochemical oxidation of NADH 
at an unmodified electrode.  
2.3.1 Entrapment 
A simple fabrication method based on the integration of a liver mitochondrial fraction 
containing glutamate dehydrogenase was employed for the fabrication of a novel glutamate 
biosensor. The liver mitochondrial fraction was utilised in an attempt to reduce the cost of 
the biosensor, however, the activity of the biosensor appeared to be compromised in 
comparison to the biosensor incorporating purified glutamate dehydrogenase. The 
biological recognition element was mixed with a carbon paste, packed into an tube, and 
used in the determination of MSG in chicken bouillon cubes [21]. The enzymatically 
generated NADH was oxidised using ferricyanide as a electrochemical mediator. High 
recoveries of MSG were achieved. Several amino acids, commonly found in food products, 
did not interfere with the determination. Extensive pre-treatment of the food sample, 
consisting of dissolving, vacuum-filtering, washing and then further diluting the sample in 
buffer, was required before analysis, in contrast to simpler food preparation methods 
previously discussed [19].  
A novel biosensor fabrication technique was developed by Tang et. al. [22] which consisted 
of entrapping GLDH between layers of alternating poly(amidoamine) dendrimer-
encapsulated platinum nanoparticles (Pt-PAMAM) with multi-walled carbon nanotubes. 
PAMAM’s were used to modify the surface of the glassy carbon electrode due to their 
excellent biocompatibility and chemical fixation properties. The procedure was repeated 
using positively charged Pt-PAMAM and negatively charged GLDH which were 
alternatively adsorbed onto the CNTs in a layer-by-layer process. The assembly process and 
enzyme immobilisation process is illustrated in Figure 2-3.  
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Figure 2-3: Schematic showing the procedure of immobilizing Pt-PAMAM onto CNTs 
(a) and the layer-by-layer self-assembly of GLDH and Pt-PAMAM onto CNTs (b). Pt-
PAMAM/CNTs heterostructures were attached covalently via EDC, Pt-PAMAM and 
GLDH were alternately deposited. Reprinted with permission from [24], Elsevier. 
Whilst the fabrication procedure is complex, the biosensor possesses superior sensitivity to 
previously discussed biosensors.  
In contrast to the above, a simpler and less time consuming method of fabricating a 
glutamate biosensor has been described [23] which involved incorporating GLDH and 
NAD+ into carbon paste. The mixture was inserted in a holder, placed in to a solution 
containing  O-phenylenediamine and subsequently electropolymerized. The o-
phenylenediamine film is simultaneously able to prevent interferences and facilitate the 
amperometric detection of NADH at low applied potentials by acting as an electron 
mediator. The biosensor was used to determine glutamate in chicken bouillon cubes; the 
results compared favourably to those obtained using a  spectrophotometric method (12.6 ± 
0.3% (n = 5) and 12.3% respectively). Despite the simpler fabrication method, the linear 
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range and sensitivity of the biosensor was lower than the sensor described by Tang et. al. 
[22]. 
In recent years, the biopolymer known as chitosan has been investigated in a variety of 
studies as a method of entrapping enzymes for biosensor construction [24]. CHIT appears to 
offer improved enzyme stability and is easy to immobilize onto a variety of materials. A 
biosensor for glutamate [25] has been constructed by depositing a mixture of purified 
CNTs, CHIT and MB onto a glassy carbon electrode and dried. The surface was then 
treated with an aliquot of GLDH in PBS, and dried at 4ºC. The cofactor was present in free 
solution at a concentration of 4mM. The selectivity of the biosensor was determined by the 
addition of interferences (AA, UA), with no apparent amperometric responses being 
generated. However, the application of the biosensor to clinical and food samples was not 
described in this paper.  
Screen-printing technology has offered the possibility of the mass production at low cost of  
glutamate biosensors; these have been successfully applied to the measurement of glutamate 
in serum and food samples [26]. As screen-printed devices are inexpensive to manufacture 
they can be considered disposable, in comparison to glassy carbon electrodes, which are 
expensive and are not considered disposable devices. Consequently, the former are much 
convenient devices for fabricating biosensors and have become a popular route to 
commercialisation. The fabrication method involved drop-coating CHIT (0.05%) onto the 
surface of a Meldola’s Blue (MB) SPCE (MB-SPCE), followed by an aliquot of glutamate 
dehydrogenase (3U/µL). This device is designated GLDH-CHIT-MB-SPCE. The biosensor 
was then left to dry under vacuum at 4ºC overnight. NAD+ was present in free solution at a 
concentration of 4mM.  
The electro-catalyst Meldola’s Blue allowed an operating potential of only +100mV to be 
employed; the response occurred as a result of the electrocatalytic oxidation of 
enzymatically generated NADH. The biosensor was successfully applied to the 
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determination of MSG in Beef OXO cubes and endogenous glutamate in serum. The beef 
OXO cube was dissolved by sonication in PBS and the endogenous content of both the 
OXO cube and serum were determined. Recoveries of 91% were attained for the spiked 
OXO cube (n = 6) and 96% for the spiked serum test (n = 6). These results compare 
favourably to those reported by Alvarez-Crespo et. al. [23] and Basu et.al [19]. This device 
improves upon the linear range of previously discussed biosensors, [23,25]. 
In order to further develop this biosensor for potential commercial development,  all of the 
components needed to be immobilized onto the surface of the transducer. The layer-by-
layer fabrication process is described in the paper [27]. The schematic shown in Figure 4 
summarises the important steps involved in this process.  
 
Figure 2-4: A schematic diagram displaying the layer-by-layer drop coating 
fabrication procedure used to construct the reagentless glutamate biosensor, based on 
a MB-SPCE electrode. Reprinted with permission from [27], Elsevier. 
An amperometric plot using the reagentless biosensor are shown in Figure 5. The biosensor 
was successfully applied to the determination of glutamate in spiked serum. A recovery of 
104% (n = 5, CoV: 2.91%) was determined, which compares favourably to previously 
discussed biosensors [19,23,26]. An interference study was conducted in both serum and 
food samples (stock cubes) and no interfering signals were generated. Such reagentless 
biosensors offer the advantage of being low cost, simple to use and requires no additional 
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cofactor to be added to the sample solution. Clearly, this is a prerequisite for commercial 
devices.   
 
Figure 2-5: Amperogram conducted with the reagentless glutamate biosensor. Each 
arrow represents an injection of 3 μL of 25 mM glutamate in a 10 mL stirred solution 
containing supporting electrolyte; 75 mM, PB (pH 7.0), with 50 mM NaCl at an 
applied potential of +0.1 V vs. Ag/AgCl. Adapted with permission from [27], Elsevier. 
2.3.2 Covalent Bonding 
The electrochemical technique known as different pulse voltammetry was used in 
conjunction with a glutamate biosensor to develop a novel assay for measuring glutamate in 
a mixture of naturally occurring biomolecules commonly found in biological samples [28]. 
The biosensor fabrication procedure involves vertically aligned carbon nanotubes 
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(VACNTs) which are treated in order to convert the tips of the CNTs into carboxylic acid 
groups, in order to covalently bind the enzyme. GLDH was bound to the CNTs using 1-(3-
dimethylamino propyl)-3-ethylcarbondiimide hydrochloride (EDC) and hydroxyl-
sulfosuccinimide sodium salt (sulfo-NHS) to promote amide linkages between the 
carboxylic tips of the CNTs and the lysine residue present on the enzyme. This was 
achieved by immersing the electrode in a solution containing EDC/sulfo-NHS and mixed. 
Once dried, the enzyme was drop-coated onto the electrode, dried for 2 hours and washed 
with PBS/BSA mixture. The DPV obtained with the synthetic samples indicated that over 
the concentration range studied, no significant interferences should be expected. However, 
the biosensor was not applied to a real sample.  
2.3.3 Crosslinking 
Carbon nanotubes have been successfully employed to produce cross linking matrixes. 
Single wall carbon nanotubes have been treated with thionine (Th) to produce a Th-
SWCNT nanocomposite on the surface of a glassy carbon electrode [29]. The 
nanocomposite acts as both an electron mediator and enzyme immobilization matrix. The 
GLDH was mixed with BSA and crossed linked with glutaraldehyde and coated onto the 
Th-SWCNT layer. An applied potential of +190mV was utilised for amperometric 
measurements. The linear range was found to superior to that which was achieved by 
Gholiazadeh et. al. [28] and Tang et. al. [22]. Ascorbic acid, uric acid and 4-
acetamidophenol were examined as possible interferents; no discernible current responses 
were seen.  
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2.4 Conclusions  
The review has highlighted some novel approaches to the fabrication of electrochemical 
glutamate biosensors. The performance characteristics of the glutamate biosensors 
discussed are summarised within Table 1. The most commonly reported method for the 
immobilization of both glutamate oxidase and dehydrogenase is entrapment.  
The utilisation of glutamate oxidase offers an advantage over glutamate dehydrogenase as 
the latter requires the cofactor NAD+ to be co-immobilised onto the appropriate transducer. 
In addition the response times are also generally shorter for glutamate oxidase based 
biosensors. However, there are several drawbacks with the use of these biosensors. 
Significantly higher applied potentials must be utilised in order to generate an amperometric 
response from the enzymatic generation of H2O2. In contrast low operational potentials of 
around 0 V can be applied with dehydrogenase based biosensors; which is advantageous 
when measuring glutamate in complex media.  
Expensive electrode materials such as gold and platinum are often used in the development 
of glutamate biosensors utilising glutamate oxidase. In contrast, three glutamate biosensors 
employing GLDH immobilized onto SPCE’s as the electrode material have been described. 
SPCE’s offer an inexpensive approach to fabricating glutamate biosensors which is clearly 
an important consideration in the commercialisation of such devices.  
Finally, the cost of glutamate dehydrogenase is far lower than that of glutamate oxidase (as 
of August 2015). 100mg (20U per mg) of glutamate dehydrogenase costs £175. By contrast, 
glutamate oxidase is sold by Sigma for £88.20 per 1U. This is clearly an important 
consideration for commercialisation. 
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Table 2-1: Details of the enzyme immobilisation technique and performance characteristics of amperometric 
glutamate biosensors based on glutamate oxidase and glutamate dehydrogenase  
Legend: NS – Not specified, N/A – Not applicable * - Voltametric Measurement, ~ - Polarographic Measurement  
 
Glutamate Oxidase based single enzyme systems 
Immobilisation Technique Type Ref LOD 
Optimum 
pH 
V (vs. 
Ag/AgCl) 
Sensitivity 
Linear 
Range 
Stability 
Response 
Time 
 
Poly(carbamoylsulphonate) 
(PCS) hydrogel mixed with 
GluOx 
 
Entrapment [11] 1.01µM 6.86 +400mV 1.94 nA/µM 
100 - 
5000µM 
90% of activity 
retained after 2 
weeks. 
NS 
 
Mixed ceria and titania 
nanoparticles for the detection 
of glutamate in hypoxic 
environments 
 
Entrapment [12] 
0.594µ
M 
7.4 
 
+600mV 
0.7937 
nA/µM 
5 – 50µM 
 
75% of signal 
after 70 assays 
in aerobic 
environment. 
Anaerobic 
enviroment, 
stable for 8 
assays. 
~5 
 
 
Biosensor for Neurotransmitter 
L-Glutamic Acid Designed for 
Efficient Use of L-Glutamate 
Oxidase and Effective 
Rejection of Interferences 
 
 
Entrapment  [13] 0.27 µM 7.4 +700 mV 
3.8 ± 1.3 nA 
cm-2 mmol-1 
L 
0 - 100µM NS <10s 
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Polyion complex-bilayer 
membrane 
 
Entrapment [14] 0.2 nM 7.0 +800 mV 1.85 nA/µM 3 – 500 µM 
Stable over 4 
weeks with 
daily usage. 
NS 
 
Carboxylated multiwalled 
carbon nanotubes/gold 
nanoparticles/chitosan 
composite film modified Au 
electrode 
 
Covalent-
bonding 
[16] 1.6µM 7.4 +135mV 
155 
nA/µM/cm2 
5 – 500 μM 
4 months, no 
data shown. 
2s 
 
Pt nanoparticles modified Au 
nanowire array electrode 
 
Entrapment [17] 14µM 7.4 +650mV 
194.6 µA 
mM-1 cm-2 
200 - 800 
µM 
 
98% of its 
initial response 
retained after 2 
weeks. 
4.8s 
 
Photo-crosslinkable polymer 
membrane on a palladium-
deposited screen-printed 
carbon electrode 
 
Cross linking [18] 0.05µM 7.0 +400mV 12.8 nA/µM 
0.05µM - 
100µM 
Stored dry – 5 
months, no 
change in 
response. 
30 – 50s 
Not stated. 
 
Cross linking with 
Glutaraldehyde and BSA as a 
spacing agent. ~ 
 
Cross linking [19] N/A 7.0 -700mV NS NS 
84% of initial 
signal after 48 
days of use 
every 3 days. 
120s 
 
Polypyrrole 
nanoparticles/polyaniline 
modified gold electrode. 
 
Cross linking [20] 0.1nM 7.5 -130mV 
533 nA/ 
µM/cm2 
0.02 - 
400µm 
60 days at 4ºC 3s 
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Glutamate Dehydrogenase based single enzyme systems 
Immobilisation Technique Type Ref LOD pH 
V (vs. 
Ag/AgCl
) 
[NAD
+/NA
D(P)+]  
Sensitivity 
Linear 
Range 
Stability 
Response 
Time 
A mixture of carbon paste, 
octadecylamine and 
mitochondria fraction, packed 
into the working electrode. 
Entrapment 
 
[21] 
 
100µM 
 
7.5 
 
+350mV 
 
1mM 
 
0.189µA/mM 
 
0.4 – 
10mM 
 
60% after 
10 days 
of use. 
 
N/A 
 
 
Alternatively assembling layers 
of glutamate dehydrogenase 
and Pt-PAMAM. 
 
Entrapment [22] 100 µM 7.4 +200mV 0.1mM 
433 µA/mM-1 
cm2 
0.2 - 250 
µM 
85% after 
four 
weeks 
3s 
 
Unmodified carbon paste 
mixed with lyophilized enzyme 
and coenzyme, packed into the 
well of a working electrode. 
 
Entrapment [23] 3.8µM 8.0 +150 mV N/A 
4·6×105 nA l 
mol−1 
5 - 78 
µM 
Signal 
decrease 
by 50% 
after 3 
days 
120s 
GLDH dropcoated onto the 
surface of a CNT-CHIT-MDB 
modified GC electrode. 
 
Entrapment [25] 2 µM 7.0 -140mV 4mM 
0.71 ± 0.08 
nA/μM 
25 – 100 
µM 
NS NS 
Immobilisation of GLDH with 
CHIT, drop coated onto the 
surface of a SPCE. 
Entrapment [26] 1.5 µM 7.0 +100mV 4mM 0.44nA/µM 
12.5 - 
150µM 
NS 2s 
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Reagentless biosensor. 
Immobilisation of both NAD+ 
and GLDH by utilising a 
mixture CHIT/MWCNT/MB 
dropcoated onto the surface of 
a SPCE in a layer by layer 
fashion. 
 
Entrapment [27] 3µM 7.0 +100mV N/A 0.39 nA/µM 
7.5 - 
105µM 
100% of 
original 
response 
retained 
after 2 
weeks 
20 – 30s 
GLDH attached to CNTs 
utilising EDC and sulfo-NHS, 
by immersing electrode in PBS 
containing both compounds 
then dropcoating GLDH. * 
Covalent 
bonding  
[28] 0.57 
µM 
7.4 NS 2mM 
With 
mediator: 
1.17 mA 
mM−1 cm−2 / 
0.153 mA 
mM−1 cm−2 
Without 
mediator: 
0.976 mA 
mM−1 cm−2 / 
0.182 mA 
mM−1 cm−2 
With 
mediator: 
0.1 - 
20µM / 
20 - 
500µM 
 
Without 
mediator 
0.1 - 
20µM / 
20 - 
300µM 
 
80.5% of 
original 
response 
after two 
weeks of 
use. 
NS 
GLDH is mixed with BSA then 
coated onto the surface of a Th-
SWNTs/GC electrode, then 
followed by glutaraldehyde.  
Crosslinking [29] 0.1 µM 8.3 
+190mV 
vs NHE 
0.1µM 
137.3 µA 
mM-1 
0.5 – 
400µM 
93% after 
2 weeks 
5s 
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Glutamate is one of the most abundant excitatory neurotransmitters and is involved in 
fundamental neurological processes such as the formation of memories and learning [1]. 
Deficiencies or abnormalities in the behaviour of neurological pathways that utilize 
glutamate and its receptors are associated with neurological disorders such as Alzheimers 
[2], schizophrenia [3] and depression [4].  
Glutamate is also a key compound in nitrogen metabolism, protein synthesis and 
degradation, and is of great physiological importance. It is the most abundant intracellular 
amino acid with concentrations varying between 2 and 20 mM [5],  whilst estimated 
extracellular levels of L-glutamate are around of 150 µM in plasma and 10 µM in 
cerebrospinal fluid [6][7].    
Glutamate metabolism is linked with the citric acid cycle [8], GABA synthesis [9] and urea 
cycle [10]. It is also linked to amino acid degradation as glutamate dehydrogenase (GLDH) 
catalyses the elimination of amino groups from amino acids. GLDH catalyses the oxidative 
deamination of glutamate to 2-oxoglutarate, using nicotinamide adenine dinucleotide 
(NAD+) as a cofactor (Figure 1-8) [11]. It is a reversible reaction, which typically favours 
glutamate formation in mammals [12]. 
Genetically expressed defects in glutamate metabolism have been recently discovered and 
lead to hyperinsulinism/hypermmonemia syndrome. [13]  
L-glutamate, in the form of monosodium glutamate (MSG), also has widespread use as a 
flavour-enhancing food additive, commonly found in Chinese food and is linked to Chinese 
Restaurant Syndrome (CRS) [14]. Thus the analysis and determination of L-glutamate is 
important for both food and clinical applications.  
The measurement of glutamate has been carried out using various analytical techniques 
such as HPLC [15], [16], capillary electrophoresis [17] and enzyme recycling in 
conjunction with microfluidic [18] and  spectrophotometric [19]  techniques. In the present 
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study we wished to explore the possibility of developing an amperometric biosensor for 
glutamate measurements. This device would offer reliability, convenience and low cost, 
particularly when fabrication was performed using screen-printing technology. We 
previously reported on the development of amperometric biosensors based on 
dehydrogenase enzymes, for lactate [20][21], alcohol [22], glucose [23] and NH4
+ [24], 
[25]. These devices were based on a screen printed carbon electrode (SPCE) incorporating 
the electrocatalyst Meldola’s Blue (MB-SPCE). MB reduces the overpotential for the 
detection of NADH, which is formed during the operation of the biosensor. Applied 
potentials close to 0 V vs. Ag/AgCl are possible. In a previous chapter [25] we reported on 
a electrochemical NH4
+ biosensor based on the reaction of this species with 2-oxoglutarate 
and NADH in the presence of the enzyme GLDH. Consequently, we considered that the 
development of a glutamate biosensor should be feasible by immobilizing GLDH onto the 
surface of a MB-SPCE and driving the overall reaction in the opposite direction by 
incorporating the oxidised cofactor (NAD+) with the enzyme.  
In this study we have investigated an immobilising procedure involving chitosan (CHIT). 
As discussed in Chapter One, Section 1.3.3.3.1, chitosan is a linear hydrophilic 
polysaccharide composed of n-acetyl-D-glucosamine and D-glucosamine units which are 
linked with a ß-(1-4) glycosidic bonds. It is a biocompantible, inexpensive, non-toxic 
biopolymer with excellent film forming properties [26] and can therefore be employed for 
enzyme immobilisation. The application of chitosan as an enzyme immobilization matrix 
has been reported previously for many different enzymes [27]. 
In the present chapter we describe the development and application of a GLDH-CHIT-MB-
SPCE biosensor for the determination of glutamate in serum and of glutamate as MSG in 
food (OXO cubes). 
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3.1 Materials and Methods 
3.1.1 Chemicals and reagents 
All chemicals were of analytical grade, purchased from Sigma Aldrich, UK, except 
glutamate dehydrogenase (CAT: 10197734001) which was purchased from Roche, UK. The 
75 mM phosphate buffer (PB) was prepared by combining appropriate volumes of tri-
sodium phosphate dodecahydrate, sodium dihydrogen orthophosphate dehydrate and 
disodium hydrogen orthophosphate dehydrate solutions to yield the desired pH. Glutamate 
and NADH/NAD+ solutions were prepared in 75 mM PB. 0.05% of chitosan was dissolved 
in 0.05 M HCl following up to 10 minutes sonication. Bovine serum albumin (BSA) 
(obtained from AbD Serotec) was used to produce dummy electrodes by drop-coating the 
same equivalent protein mass as glutamate dehydrogenase. Fetal bovine serum (FBS) 
(South American Origin, CAT: S1810-500) obtained from Labtech Int. Ltd, was used for 
serum analysis. Food samples (Beef OXO cubes) were obtained from a local supermarket.   
3.1.2 Apparatus 
All electrochemical experiments were conducted with a three-electrode system consisting of 
a carbon working electrode containing MB-SPCE (Gwent Electronic Materials Ltd; Ink 
Code: C2030519P5), Ag/AgCl reference electrode (GEM Product Code C61003P7):  
printed onto PVC, and a separate Pt counter electrode. The area of the working electrode 
was defined using insulating tape, into a 3 x 3 mm square area. The electrodes were then 
connected to the potentiostat using gold clips. Solutions, when required, were stirred using a 
circular magnetic stirring disk and stirrer (IKA® C-MAG HS IKAMAG, Germany) at a 
fixed speed. A µAutolab II electrochemical analyser with general purpose electrochemical 
software GPES 4.9 was used to acquire data and experimentally control the voltage applied 
to the SPCE in the 10 ml electrochemical cell. An AMEL Model 466 polarographic 
analyser combined with a GOULD BS-271 chart recorder was used for some amperometric 
studies. Measurement and monitoring of the pH was conducted with a Fisherbrand Hydrus 
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400 pH meter (Orion Research Inc., USA). Sonications were performed with a Devon 
FS100 sonicator (Ultrasonics, Hove, Sussex, UK). 
3.2 Procedures 
3.2.1 Fabrication of glutamate biosensor  
A 0.05% HCl solution containing CHIT was drop-coated onto the surface of the unmodified 
MB-SPCE 9mm2 working electrode and left to dry under vacuum. Once dried the enzyme 
GLDH with the appropriate quantity of units was drop-coated directly onto the CHIT layer. 
The same procedure was used to obtain dummy biosensors by using CHIT and the same 
mass of BSA as that of the enzyme. Figure 3-1 illustrates the proposed GLDH-CHIT-MB-
SPCE biosensor.  The biosensors were stored in a desiccator, shielded from light at 4ºC 
overnight to allow the enzyme layer to dry. 
 
 
 
 
Figure 3-1) Diagram of proposed biosensor strip. The insulating tape defines both the 
WE and RE. CHIT is then drop-coated and allowed to dry, followed by GLDH. All 
studies were conducted using a separate Pt wire counter electrode. 
Serum and food samples were analysed (n = 3) for interferences using dummy biosensors.  
If interferences were detected, the average signal generated was deducted from the enzyme 
biosensor response.  
 
 
Ag/AgCl RE 
Insulating 
tape 
CHIT 
GLDH 
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3.2.2 Calibration studies of the biosensor using amperometry in stirred 
solution. 
All amperometric measurements were performed in stirred solutions using an applied 
potential of +0.1 V vs. Ag/AgCl. Measurements of glutamate were conducted in 75 mM PB 
(pH 7.0) containing 4 mM of NAD+ and 50 mM NaCl using the GLDH-CHIT-MB-SPCE. 
The biosensor was immersed into a stirred 10 mL buffer solution, the potential applied and 
sufficient time was allowed for allowed a steady-state current to be obtained. The 
amperometric responses to additions of known concentrations of glutamate were then 
recorded. Amperometry was used to determine the effects of pH (5 – 9) and temperature (25 
- 40°C) by examining the performance characteristics over the concentration range of 25 
µM to 300 µM glutamate.  
3.2.3 Application of optimised amperometric biosensor (GLDH-CHIT-MB-
SPCE) to the determination of glutamate in food.  
OXO cubes (5.9g, average mass of three OXO cubes) were prepared by dissolving one cube 
in 50 mL of PB and sonicating for 15 minutes. The endogenous concentration of MSG was 
determined by using the method of standard addition. An initial 10µl volume of the 
dissolved OXO cube was added to the stirred buffered solution (10 mL) in the voltammetric 
cell containing the biosensor, operated at +0.1 V (vs. Ag/AgCl) with subsequent standard 
additions of 10µL of 25 mM glutamate. 
The reproducibility of the biosensor assay for MSG analysis in OXO cubes was determined 
by repeating the whole procedure six times with six individual biosensors. The effects of 
interferences from the OXO cube were established by using a dummy BSA biosensor and 
deducted from the enzyme biosensor signal.  
The recovery of MSG added to OXO cubes was investigated by fortifying the solution 
containing one OXO cube with 100 mM of glutamate. The analysis of this solution was 
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performed in a similar manner to that described for the unfortified solution. In this case, an 
aliquot of only 2µL of the fortified OXO solution was added to 10mL volumes of buffer 
solution. Standard additions of 2.5uL of 100 mM glutamate were added to this mixture.  
3.2.4 Application of optimised amperometric biosensor (GLDH-CHIT-MB-
SPCE) to the determination of glutamate in serum. 
To determine the original glutamate concentration, an initial volume of 100 µL of serum 
was added to 9.9mL of buffered solution. The serum solution was subjected to amperometry 
in stirred solution using an applied potential of + 0.1 V vs. Ag/AgCl. This was followed by 
additions of 10 µL aliquots of 25 mM standard glutamate solution to the voltammetric cell. 
The currents resulting from the enzymatic generation of NADH were used to construct 
standard addition plots, from which the endogenous concentration of glutamate was 
determined. The reproducibility of the biosensor was deduced by repeating the studies six 
times with six individual biosensors. 
The procedure was repeated using serum spiked with 2 mM glutamate (n = 6) to determine 
to the recovery of the assay. The effects of the interference from serum were established by 
using a dummy BSA biosensor. A dummy biosensor was constructed by drop coating the 
equivalent weight of the enzyme with BSA.  
3.3 Results and Discussion 
3.3.1 Principle of Operation of the Biosensor 
The overall principle of operation of the biosensor is shown in Figure 3-2. Glutamate in 
solution is oxidised to form 2-oxoglutarate in the presence of the immobilized enzyme 
glutamate dehydrogenase (GLDH) and NAD+; the product NADH and NH4
+ are formed 
during this reaction.  The NADH diffuses through the CHIT layer to reach the electrode 
(Fig. 3-1), where it undergoes oxidation by the MBox which is reduced to MBred. The 
electrochemical oxidation of MBred
 to MBox occurs at an applied potential of +0.1 V vs. 
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Ag/AgCl and produces the analytical response (Fig. 3-2) The value of +0.1 V was deduced 
by constructing a hydrodynamic voltammogram and selecting the potential from the 
position of the plateau (Fig. 3-3). 
 
Figure 3-2: Schematic displaying the interaction between the immobilized enzyme 
GLDH and glutamate at the surface of the electrode and the subsequent generation of 
the analytical response.  
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Figure 3-3 Cyclic voltammograms illustrating an increase in the current related to an 
increase in the concentration of NADH. Scan rate 20mVs, -0.5V - 1.3V scan range.
 
Figure 3-4: Hydrodynamic voltammogram plot of GLDH-CHIT-MB-SPCE in the 
presence of 1mM NADH, in 10mL of supporting electrolyte; 75mM, PB (pH 7.0) and 
50 mM NaCl. 
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3.3.2 Immobilisation of GLDH using chitosan 
During initial studies when drop-coating the GLDH onto the surface of the MB-SPCE 
alone, steady-state currents were not produced. Additions of glutamate produced 
inconsistent currents, suggesting that the GLDH may have been dissipating into the free 
solution, producing sporadic current responses. Studies conducted to investigate the use of 
glutaraldehyde and cellulose acetate; both commonly used enzyme binding agents, failed to 
generate steady-state currents or produced little to no signal response, indicating loss of 
enzyme into solution. CHIT was therefore applied to the surface of the biosensors to 
fabricate GLDH-CHIT-MB-SPCE devices; subsequent additions of glutamate produced 
consistent steady state responses with this approach. 
3.3.3 Optimisation Studies 
The response of the GLDH-CHIT-MB-SPCE biosensor to changes in temperature was 
investigated using concentrations of glutamate over the range 12.5 to 250 µM prepared in 
75 mM phosphate solution (pH 7.0). The effect of temperatures between 25 to 40°C was 
studied. The maximum amperometric response was found to occur at 35°C (Figure 3-4). 
The decrease occurring above 35°C may be due to enzyme denaturing at higher 
temperatures. It may be noted that the linear range was highest using 30°C which could be 
beneficial in some applications.  
The effect of pH was investigated over the pH range 5 – 9 (Figure 3-5). The highest 
sensitivity (0.18 nA/µM) was obtained at pH 9, with a near-linear decrease down to a pH of 
5. However, the linearity of the responses showed an inverse trend with the greatest linear 
range occurring at pH 5, decreasing down to a pH of 9. 
B 
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Figure 3-5: Illustrates the effects of temperature upon the current response of the 
biosensor to injections of glutamate up to 275 µM in 25µM steps 
 
Figure 3-6: Illustrates the effects of pH upon the current response of the biosensor to 
the addition of glutamate. An applied potential +0.1V vs. Ag/AgCl in 10 ml of 75 mM 
phosphate buffer solution containing 50 mM NaCl was used. 
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3.3.4 Calibration Studies 
Calibration studies with glutamate were conducted with the fully developed glutamate 
biosensor using the optimized experimental conditions over the concentration range 25µM 
– 275 µM . The biosensor exhibited a sensitivity of 0.44 nA/µM (n = 3). The calculated 
limit of detection (based on three times signal-to-noise) was 1.5 µM, thus the biosensor is 
clearly appropriate for analysing extracellular concentrations of glutamate in clinical 
applications. 
 
Figure 3-7: Calibration plot depicting the full range over which the calibration study 
was conducted with the glutamate biosensor. As illustrated by the plot, once the 
concentration of glutamate exceeds 150µM, the Km has been exceeded. Std deviations 
are based on n = 3. Conditions: 35ºC, pH 7.  
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3.3.5   Application of the optimum amperometric biosensor (GLDH-CHIT-
MB-SPCE) to the determination of glutamate in unspiked and spiked 
food.  
Many food products are known to contain MSG as a flavour enhancer, therefore, we 
decided to explore the possibility of applying our new glutamate biosensor to a known 
brand of beef stock cube.  
A standard addition study was conducted by dissolving one OXO cube (5.916 g mass) in 
50ml of PB using sonication for 15 minutes. Six replicate OXO cube samples were analysed 
using fresh biosensors for each measurement. The determination was performed by filling 
the cell with 9.99 mL of electrolyte, establishing a steady state current, and then injecting a 
10µL volume of unfiltered OXO cube in PB solution with subsequent 10µL injections of 25 
mM glutamate (Figure 3-6A). The mean quantity of glutamate discovered in unspiked OXO 
cubes (n = 6) was 125.43 mg/g with a coefficient of variation of 8.98%. Results are shown 
in Table 3-1. A standard addition calibration plot is shown in Figure 3-8.  
GLDH-CHIT-MB-SPCE biosensors were used to determine glutamate in spiked OXO 
cubes. The OXO cube was spiked with 100 mM of glutamate, doubling the endogenous 
level of glutamate found in OXO cube stock. The standard addition method employed for 
the unspiked OXO cubes was altered by changing the initial injection of spiked OXO cube 
solution to 2µL. The mean recovery (n = 6) was a 91% with a CV of 6.39% (Table 3-1) 
This result indicated high reproducibility for biosensor in what was a complex, unfiltered 
medium. 
Interestingly the endogenous content of MSG in OXO cubes measured by our gave similar 
values for stock cubes containing MSG analysed by both HPTLC [28] and an optical 
biosensor [29]; values of 133.50 mg/g and 182.9 mg/g were detected by the named methods 
respectively. 
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Figure 3-8) A. Amperogram obtained using a GLDH-CHIT-MB-SPCE with a solution 
containing 10µL of a dissolved OXO cube; arrows indicate additions of 10µL of 25 
mM glutamate into a 10mL volume. Measurements taken 1.5 min after each addition. 
 
Current (nA) 
Time (min) 
A 
10µL of OXO 
10µL of 25 mM Glutamate 
Chapter Three 
91 
 
 
Figure 3-9: Typical standard addition calibration plot obtained with a solution 
containing a dissolved OXO cube using a GLDH-CHIT-MB-SPCE. Standard error 
bars based on n = 6. 
Unspiked OXO Cube 
Sample Quantity of Glutamate 
Detected (mg/g) 
1 114.15 
2 147.29 
3 129.37 
4 113.96 
5 125.47 
6 122.35 
Mean (mg/g) 125.43 
Std Dev 11.26 
CV (%) 8.98 
Table 3-1) Data obtained from the unspiked OXO cube/food study. The mean 
endogenous concentration was 125.43 mg /g (n = 6) in unspiked OXO cubes.  
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Figure 3-10: Typical standard addition calibration plot obtained with a solution 
containing a dissolved spiked OXO cube using a GLDH-CHIT-MB-SPCE. Standard 
error bars based on n = 6. 
Table 3-2) Data obtained from the spiked OXO cube/food study.  
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Spiked OXO Cube 
Sample Endogenous 
Concentration 
mg/g 
Spike mg/g Total 
Concentration 
Found mg/g 
Recovery 
(%) 
1 125.43 158.03 266.05 86 
2 125.43 158.03 268.20 88 
3 125.43 158.03 280.11 97 
4 125.43 158.03 279.03 96 
5 125.43 158.03 273.73 92 
6 125.43 158.03 262.15 83 
Mean 
(%) 
91 
Std Dev 6.00 
CV (%) 6.39 
Chapter Three 
93 
 
3.3.6 Application of the optimum amperometric biosensor (GLDH-CHIT- MB-
SPCE) to the determination of glutamate in both unspiked and spiked 
serum. 
Amperometry, in conjunction with the method of multiple standard additions was 
conducted to determine the endogenous levels of glutamate and the recovery for serum 
spiked with additional glutamate. The replicate serum samples were analysed using a fresh 
biosensor for each measurement.  
The data obtained on serum samples using the glutamate biosensor are shown in Table 3-2. 
The endogenous levels of glutamate detected were 1.68 mM for the unspiked samples. The 
coefficient of variation was 4.09% for the six individual samples. This concentration is 
above that discovered by Ye and Sontheimer in 1998 [30] who discovered concentrations 
ranging from 808.2 μM to 1195.7 μM in fetal bovine (calf) sera (FBS) using a 
bioluminescence detection method. However, this study did not include the provider of 
serum nor the South American variety used in studies conducted using the GLDH-CHIT-
MB-SPCE biosensor, thus glutamate concentrations may potentially be higher in different 
batches given the variation displayed. These results show promise due to the low coefficient 
of variation, small amount of serum required to carry out analysis and the lack of 
preparation steps. 
The GLDH-CHIT-MB-SPCE biosensors were then used to determine glutamate in spiked 
serum. The serum was spiked with 2.00 mM glutamate so as to roughly double the 
endogenous levels of glutamate and to allow a distinction between the spike and 
endogenous levels. The results are shown in Table 3-3. The mean recovery (n = 6) was 96% 
with a CV of 3.29% indicating high reproducibility in serum. This method offers an 
economical and simple approach for the screening of glutamate levels in serum.  It should 
be mentioned that the biosensors were stored in a desiccator in a refrigerator at 4°C before 
use; under these conditions they were found to be stable for at least one week.  
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Figure 3-11: Typical standard addition calibration plot obtained with a serum solution 
using a GLDH-CHIT-MB-SPCE. Standard error bars based on n = 6. 
Unspiked Serum   
Sample Concentration 
of Glutamate 
detected (mM) 
 
1 1.70  
2 1.54  
3 1.67  
4 1.76  
5 1.69  
6 1.71  
Mean (mM) 1.68  
Std Dev 0.07  
CV (%) 4.10  
Table 3-3) Data obtained from the unspiked serum study. In unspiked serum, 1.68 
mM of glutamate was detected (n = 6) with a coefficient of variation of 4.1%.  
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Figure 3-12: Typical standard addition calibration plot obtained with a serum solution 
using a GLDH-CHIT-MB-SPCE. Standard error bars based on n = 6. 
Spiked Serum   
Sample Spike 
mM 
Endogenous 
Concentration 
mM 
Total 
Concentration 
Found mM 
Recovery 
(%) 
1 2.00 1.68 3.52 92 
2 2.00 1.68 3.65 98 
3 2.00 1.68 3.62 97 
4 2.00 1.68 3.65 99 
5 2.00 1.68 3.62 97 
6 2.00 1.68 3.49 90 
Mean (%) 96    
Std Dev 3.14 
CV (%) 3.29 
Table 3-4) In spiked serum, the mean recovery was 96%, coefficient of variation 3.29 
% (n = 6). 
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The GLDH-CHIT-MB-SPCE biosensor described in this chapter possesses a superior limit 
of detection by comparison to other biosensors utilising glutamate dehydrogenase and can 
be fabricated simply in comparison to those reported previously (Table 3-5). Consequently, 
these devices hold promise for application quality control in clinical laboratories. It is 
interesting to note that a biosensor based on glutamate oxidase [31] has been reported for 
the determination of glutamate in soy sauce; a detection limit of 10nM was achieved. 
However, it should be mentioned that the operating potential required to detect H2O2 was 
+950mV, as a result the selectivity of the device may not be sufficient for the analysis of 
glutamate in serum. 
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Immobilization Method 
 
Ref LOD pH 
Applied 
Potential 
[NAD+] Sensitivity 
Linear 
Range 
Response 
Time 
GLDH attached to the inner 
surface of a 75µM i.d. 
capillary using biotin-avidin 
chemistry. NADH measured 
by fluorescence. 
[32] 3 µM 
8.5, but 
saline 
7.3 also 
used. 
- 3 mM - - 450ms 
Glassy carbon covered in 
CNT-CHIT-MDB 
composite film. GLDH in 
PBS was caste on the CNT 
composite electrode. 
[33] 2 µM 7.2 -100 mV 4 mM 0.71 ± 0.08 nA/µM N/A ~10s 
GLDH and diaphorase 
immobilized on a 
nanocompositie electrode. 
[34] 
5.4 
µM 
9.0 +300 mV 2 mM 
28 nA μM 
−1cm−2 
10 - 3495µM - 
Polymer-modifid electrode. 
MB entrapped into two 
polymers 
[35] 2 µM 7.4 0 mV 1 mM 0.70 nA µM-1 0 - 100µM  
Nanomolar Detection of 
Glutamate at a biosensor 
based on Screen-printed 
Electrodes modified with 
Carbon Nanotubes 
 
[31] 10 nM 7.4 +950 mV N/A 
0.72nA ± 0.05 μA 
µM-1 
0.01 – 10 
µM 
<5s 
 
GLDH-CHIT-MB- SPCE 
 
This 
study. 
1.5 
µM 
7.0 +100 mV 4 mM 0.44 nA/µM 
12.5 - 150 
µM 
~2s 
Table 3-3) A comparison of previously reported Glutamate biosensors, including the one described in this chapter. 
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3.4 Conclusions 
This chapter has demonstrated the effective use of CHIT to immobilise GLDH onto the 
surface of a MB-SPCE for the fabrication of a glutamate biosensor and the successful 
application of the biosensor to the determination of glutamate, in both serum and food 
samples, without any sample pre-treatment, other than dilution.  
This simple approach is attractive as it is based on an electrochemical biosensor fabricated 
by incorporating biological compounds with a chemically modified screen printed carbon 
electrode. SPCE’s can be mass produced at low cost so biosensors based on this technology 
can be considered disposable. This latter feature may be of significance in biological fluid 
analysis where contamination may be an issue. 
In summary our proposed biosensor approach offers the advantages of good selectivity 
owning to the combination of an enzyme integrated with a transducer operated at a low 
potential of only +100mV, coupled with the simplicity of fabrication and analytical 
operation.  
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4.1. Introduction 
In Chapter 3, a non-reagentless biosensor was described for the determination of glutamate. 
Glutamate dehydrogenase was bound to the surface of the biosensor utilising CHIT, whilst 
NAD+ was present in free solution. As described in Chapter 1, microband electrodes 
possess unique properties which could be utilised and applied to real time toxicity testing. 
The development of pharmaceutical compounds is a costly and extensive process, with 
product development costing up to 30 – 35% of bringing a new drug to the market [1]. 
Early development candidates for drug development are selected based on their 
pharmacological and toxicological properties which are investigated through early-stage in 
vitro cell based assays [2]. Cytotoxicity assays such as neutral red, MTT, LDH leakage and 
protein assays are used to evaluate the number of dead cells [3]. Pemberton et. al. [4], [5] 
have described the development and application of a glucose microband biosensor for the 
real time monitoring of glucose uptake in HepG2 cells, that have been exposed to different 
concentrations of paracetamol in real time. The authors have shown the possibility of using 
cell monitoring in conjunction with electrochemical biosensor towards the eventually 
replacing of animals in toxicity testing in drug development. This cell line has previously 
been applied as a model for the real time monitoring of toxic challenge by measuring the 
inhibition of the uptake of glucose [5], the release of lactate [6] and both glucose and lactate 
simultaneously [7].  
The concentration of intracellular glutamate is typically higher than that of extracellular 
glutamate. For example, within the brain, extracellular glutamate concentrations are 
normally within the 1 – 10µM range [8], [9] whilst intracellular glutamate concentrations 
are typically in the micromolar range [10]. Similar micromolar levels have been observed 
intracellularly in rat livers [11], [12].  
The use of electrochemistry for the real time acquisition of metabolic data, towards the 
potential reduction of animal testing, is highly desirable both ethically and to improve the 
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reliability of drug testing using human cells. Toxicity testing in environmental monitoring 
and food safety has become of increasing interest [13], [14].  Electrochemical biosensors 
are capable of high specificity towards the target analyte of interest when utilising a low 
operating potential and incorporating the appropriate enzyme and cofactors to the surface of 
the electrode.  
This small dimension results in advantageous properties such as low ohmic drop, increased 
mass transport via radial diffusion and small double layer capacitance thereby improving 
the signal to noise ratio [15]. The microband biosensor was fabricated by drop coating a 
“bio-cocktail” of chitosan (CHIT), nicotinamide adenine dinucleotide (NAD+) and 
glutamate dehydrogenase (GLDH), onto the working area of a Meldola’s Blue screen-
printed carbon electrode (MB-SPCE). The working area of the biosensor, once the 
biological components had dried, was covered with insulating tape. The microelectrode 
biosensors were fabricated by cutting through the covered working expose an edge that 
measures in micrometers in one dimension. This simple fabrication procedure is utilised to 
construct a reagentless glutamate microband biosensor.  
As mentioned in Chapter 3 a non-reagentless glutamate biosensor has previously been 
developed by drop-coating the required components onto the working electrode of screen-
printed carbon electrodes [16]. This chapter discusses the development of a reagentless 
glutamate microband biosensor, employing CHIT, NAD+, GLDH and MB-SPCE in a 
simple fabrication method. The application of this microband biosensor is for the real time 
monitoring of glutamate flux from cells in response to toxic challenge is described. The 
scientific novelty is present in both in the simplicity of fabrication of the reagentless 
microband biosensor and its application to post-exposure and real time toxicity testing in 
cell media.  
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4.2. Materials and Methods 
4.2.1. Chemicals and Reagents 
Foetal bovine serum (FBS), Minimum Essential Medium Eagle (MEM) and all other 
chemicals were purchased from Sigma-Aldrich. All chemicals were of analytical grade, 
purchased from Sigma Aldrich, UK, except glutamate dehydrogenase (CAT: 10197734001) 
which was purchased from Roche, UK. The 75 mM phosphate buffer (PB) was prepared by 
combining appropriate volumes of tri–sodium phosphate dodecahydrate, sodium 
dihydrogen orthophosphate dihydrate and disodium hydrogen orthophosphate anhydrous 
solutions to yield the desired pH. Glutamate and NADH/NAD+ solutions were dissolved 
directly in 75 mM PB. Chitosan (CHIT) was dissolved in 0.05 M HCl (pH < 3.0) to produce 
a 0.05% solution following up to 10 minutes sonication. A 25mM stock solution of 
glutamate (monosodium glutamate, MSG) was utilised for glutamate calibrations. A 
100mM stock of paracetamol in 100% ethanol was diluted by 1/5th with cell culture media 
and filtered sterilised (0.2µm) before use.  
4.2.2. Apparatus 
All electrochemical studies were conducted with a two electrode system consisting of a 
carbon working electrode containing MB (MB–SPCE, Gwent Electronic Materials Ltd; Ink 
Code: C2030519P5), a Ag/AgCl reference electrode (GEM Product Code C61003P7); both 
printed onto PVC. The electrodes were then connected to the potentiostat using gold clips. 
Microband electrodes/biosensors and reference electrodes were held by gold clips attached 
to cork lids which were push-fitted into 6-well plate wells. Electrodes were connected to a 
PG580RM 5-channel potential (Uniscan Instruments Ltd, Buxton, UK; www.uniscan.com) 
which was controlled using UiEChem software (Version 2.02), for both single and multiple 
parallel well studies. All cell culture work such as feeding, splitting the cells and dosing 
with paracetamol was conducted under a sterile fume hood. The cork lid electrode holders 
was sterilised with 70% ethanol spray in order to reduce contamination. The electrodes 
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themselves were not sterilised as the ethanol would potentially damage the enzyme and 
cofactor. Studies utilising MEM and HepG2 cells were carried out in an incubator with a 
5% CO2
 atmosphere at 37ºC in order to maintain the pH of the cell media. Solutions, when 
required, were stirred using a IKA MS 1 Minishaker. Measurement and monitoring of the 
pH was conducted with a Fisherbrand Hydrus 400 pH meter (Orion Research Inc., USA). 
Sonications were performed with a Devon FS100 sonicator (Ultrasonics, Hove, Sussex, 
UK). 
4.2.3. Biosensor Fabrication 
The biosensor fabrication procedure is illustrated in Figure 4-1 (a-e). Briefly, microband 
biosensors were fabricated by drop coating (a) 5µL of CHIT (0.05% in 0.05M HCl) onto the 
surface of a 3mm2 working electrode, followed by (b) 9µL of GLDH (3U/µL) and 1µL of 
NAD+ (106µg). (c) The biosensor was then left to dry overnight at 4ºC. (d) Once dried, 
insulating tape was used to cover the working area and some of the electrode track. (e) The 
covered area of the working electrode was cut through using a scissors to expose a 3mm-
long working electrode edge. The technique has previously been utilised to successfully 
fabricate microband electrodes for the measurement of glucose [17] and hydrogen peroxide 
[6].  
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Figure 4-1: A step-by-step diagram of the fabrication of the reagentless glutamate 
biosensor. a) Drop coating of CHIT b) drop coating of GLDH and NAD+ c) drying d) 
application of insulating tape across working area of electrode e) cutting through 
working electrode to expose the microband biosensor.  
4.2.4. Electron Microscopy 
The microband biosensor was attached to a 9 mm-diameter double sided adhesive carbon 
disc on a 45º angled aluminium stub. A cross section of the edge of the electrode was 
examined using a Philips XL30 environmental scanning electron microscope (ESEM).  
4.2.5. Voltammetry and amperometry 
Each cyclic voltammogram or amperogram, was obtained by lowering a microband 
biosensor, in combination with a screen-printed Ag/AgCl reference electrode, into the 
voltammetric cell containing a quiescent 10 ml solution of 0.75 M phosphate buffer 
containing 5mM NADH, plain 0.75 M phosphate buffer or culture medium. For the 
voltammetric characterisation of NADH the following procedure was employed; phosphate 
buffer solution was degassed with nitrogen for 5 minutes, 15 s equilibration at open circuit 
voltage, working electrode potential scanned from -0.5 V to +0.6V to -0.5V at a scan rate of 
5mV/s  
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For amperometric calibration studies the voltage was switched directly from open circuit to 
the appropriate applied potential (+0.1 V vs. Ag/AgCl). Solutions were agitated with a 
gyrorotator at a fixed speed for both phosphate buffer and cell media studies. This was in 
order to facilitate diffusion and improve the homogeneity of the solution.  
Initially, studies were carried out with the biosensor in phosphate buffer solutions 
containing glutamate in order to determine whether the performance was suitable for the 
subsequent monitoring of cells. Amperometry, over prolonged times in cell culture, was 
performed by applying a potential of +0.1 V to the micro-band biosensor immersed in a 6 
ml volume of cell culture medium in the well of a  6-well plate, containing HepG2 cells and 
paracetamol where appropriate. The resulting real time current responses were recorded 
over a period of 8 hours.   
4.2.6. HepG2 cell culture 
The HepG2 (Human Caucasian Hepatocyte Carcinoma) cell line (obtained from ECACC) 
was cultured as a monolayer in 75 cm2 flasks, in a 5% CO2-in-air atmosphere at 37 °C, at an 
initial density of 2*105 cells cm−2. Cells were counted using a haemocytometer. The 
medium was MEM containing 10% FBS, 1% non-essential amino acids (NEAA), 200 nM 
L-glutamine. When confluent, the cells were detached by trypsinisation, and resuspended in 
MEM containing FBS, NEAA and glutamine at the same initial density. For the assays 
described, cells were plated at a density of 2 x 106 cells mL−1 in 6 mL volumes into 6-well 
tissue culture plates.  
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4.2.7. Real time monitoring of glutamate in cell culture media in the 
presence/absence of cells and toxic compounds. 
HepG2 cells grown in T75 flasks, once 80% confluent were trypsinized and transferred to 
six well tissue culture plates, along with 6mls of cell media under sterile conditions. 24 
hours were allowed to pass to allow the cells to fully adhere to the bottom of the cell well. 
Once adhered, appropriate aliquots of paracetamol (100mM in 20% ethanol, diluted with 
cell culture medium) were added to the wells in order to achieve the desired concentration. 
The cork lids carrying a microband glutamate biosensor and reference electrode were push-
fitted into each well. A small (1 mm diameter) hole in the top surface of each sensor cork 
lid allowed air to escape, avoided pressure build-up during the push-fitting step and allowed 
for gaseous exchange to maintain the pH of the media. The non-essential amino acids 
(NEAA) added to the cell culture media was found to contain a small concentration of 
glutamate (0.31µM) which may have contributed to the background current.   
Electrical contact was made through the temperature seal of the incubator and connected to 
respective channels of the multichannel potentiostat. The 6-well plate was rotated utilising a 
mini-shaker within an incubator at 37 °C, 5% CO2 in the air atmosphere. An operating 
potential of +0.1 V vs Ag/AgCl was applied to each working electrode, and the instrument 
was run in amperometric mode 8 hours for the real time studies. The resulting data were 
exported into Microsoft Excel and plotted as current-versus time graphs.  
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4.3. Results and discussion 
4.3.1. Microband biosensors 
An SEM image of the edge of the microband electrodes based on MB-SPCE are shown in 
Figure 4-2. Each layer of the biosensor is labelled, with each layer visible. The thickness of 
the original MB-SPCE working electrode is about 20 µm, thus the sensor is defined as a 
microband biosensor. The exposed edge of the microband electrode possesses an area of 
60,000 square µm (3mm x 20µm).  
 
Figure 4-2. SEM image of the cross section of the microband biosensor electrode.  
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4.3.2. Electrochemical Characterisation in NADH utilising Cyclic Voltammetry 
The cyclic voltammogram for the Meldola’s Blue microband electrode in a solution 
containing 0.75mM PBS, 0.50 mM NaCl, pH 7 and 5mM NADH, the resulting cyclic 
voltammogram (Figure 4-3A) showed sigmoidal behaviour, with an increased current 
response, which confirms that the response is due to the electro-catalytic oxidation using the 
MB-SPCE [18]. This electrocatalytic response for NADH is a prerequisite for the operation 
of the amperometric glutamate microband biosensor. The blank carried out in the same 
solution in the absence of NADH showed a peak shape response indicative of a surface 
confined layer of Meldola’s Blue (Figure 4-3, B, C).  
 
Figure 4-3: Cyclic voltammograms of a reagentless glutamate biosensor in the 
presence (A) and absence of 2.5 (B) and 5mM NADH (C) (PBS, pH 7.0). Scan rate at 
5mVs.  
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4.3.3. Calibration studies of glutamate in phosphate buffer solution.  
Amperograms obtained with the microband biosensors in agitated phosphate buffer 
solutions (0.75mM with additional 0.5mM NaCl) at an applied potential +0.1V (Ag/AgCl) 
are shown in Figure 4-4. The corresponding calibration plot is shown in Figure 4-5. Arrows 
indicate aliquots of 6µL of a 25mM glutamate stock solution into 6mLs of buffer. The 
standard deviations represented are based on n = 5. The biosensor, operating in phosphate 
buffer possessed the following characteristics; linear range; 25 - 125µM, sensitivity; 0.0636 
nA/µM and a theoretical limit of detection of 1.20µM (based on 3*S/N). All studies were 
carried out at 37ºC, pH 7.0. We considered that these characteristics were suitable for 
further studies with cell media. The current density for the biosensor in phosphate solution 
was calculated to be 5µA/cm2, which is quite low for a microband biosensor. A study 
investigating the voltammetric behaviour of the microband biosensor in the presence of 
5mM ferricyanide resulted in a current density of 740µA/cm2, indicating that the Meldola’s 
Blue is the rate limiting step.    
4.3.4. Amperometric studies of glutamate in cell media. 
Amperograms obtained with the microband biosensors in agitated MEM cell media at an 
applied potential +0.1V (Ag/AgCl) are shown in Figure 4-6. The arrows indicate aliquots of 
6µL of a 25mM glutamate stock solution into 6mLs of buffer The corresponding calibration 
plot is shown in Figure 4-7. The standard deviations rare based on n = 3. The biosensor, 
functioning in cell media, possessed the following characteristics; linear range; 25 – 150 
µM, sensitivity; 0.128 nA/µM and a theoretical limit of detection of 4.2µM (based on 
3*S/N). All studies were carried out 37ºC, pH 7.0, in-air-atmosphere of 5% CO2. At this 
point the biosensor assay appeared to be suitable for our proposed real time cell toxicity 
studies.  
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Figure 4-4: A) Amperogram conducted with the reagentless glutamate microband biosensor in phosphate buffer (pH 7). Each arrow 
indicates an aliquot of 6µL of a 25mM glutamate stock solution into 6mLs of buffer.  
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Figure 4-5: Resulting calibration plot. Standard deviation bars are based on n = 5). Sensitivity: 0.0627nA/µM  
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Figure 4-6: A) Amperogram conducted with the reagentless glutamate microband biosensor in cell media. Each arrows indicate an 
aliquot of 6µL of a 25mM glutamate stock solution into 6mLs of cell media.  
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Figure 4-7: Resulting calibration plot. Standard deviation bars are based on n = 5. Sensitivity: 0.1298nA/µM 
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Fully confluent HepG2 cells were exposed to various concentrations of paracetamol (1mM, 
5mM and 10mM) for 24 hours. After exposure, the cell media was collected and the cells 
were discarded. The microband biosensor was initially submerged in blank untreated cell 
media, then once steady state was reached the biosensor was transferred to the post-
exposure cell media. This resulted in an increase in current as a result of the additional 
glutamate released from inside the HepG2 cells after exposure to paracetamol exposure. 
Once steady state had been reached, aliquots of 25mM glutamate were added to the cell. 
The response generated by the endogenous glutamate present in the cell media was 
substrate and the resulting current increases from the additions of glutamate were plotted 
against concentration. A standard addition calibration plot was constructed in order to 
determine the original concentration of glutamate found in the cell media.  
 
Figure 4-8: Bar chart illustrating the concentrations of glutamate present in cell media 
24 hours post incubation in the presence of various concentrations of paracetamol. Std 
deviations based on n = 3.  
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The average endogenous concentrations for glutamate released from the HepG2 cells was 
52.07µM (CoV: 13.74%, n = 3), 93.30µM (CoV: 18.41%, n = 3) and 177.14µM (CoV: 
14.54% n = 3) for 1mM, 5mM, 10mM doses of paracetamol respectively. A t-test to analyse 
the significance of the values for 1mM and 5mM doses of paracetamol. A p value of less 
than 0.05 was generated, implying the difference between the two values is significant 
(Appendix Table 1). The resulting dose response plot is shown in Figure 4-8. The standard 
deviations shown are based on n = 3. Typical intracellular glutamate levels are 2 – 5 mM/L 
[19][20].  
4.4. Real-time monitoring of glutamate release from HepG2 cells exposed to 
various concentrations of paracetamol.  
Microband biosensors were placed into six-well plates containing fully confluent HepG2 
cells exposed to various concentrations of paracetamol (1mM, 5mM and 10mM) for 8 
hours. Microband biosensors were placed into the wells which monitored the release of 
glutamate and other constituents from the cells in real time by amperometry. Figure 4-9 
illustrates the electrode holder, six well plate and minishaker setup within an incubator for 
the real time studies. The minishaker was utilised in order to assist diffusion and decrease 
the response time. The electrode holder consists of a cork lid which has been pierced with 
gold electrode clips. The exposed ends of the gold clips are connected to a “chocolate” 
block connector, which is wired directly one of the ports on the potentiostat. This enables 
the biosensor to be attached to the gold clips on the underside of the cork lid and be 
submerged in the cell media solution.  
This method offers numerous advantages over a typical electrode holder setup. Firstly, the 
cork-lids reduce the evaporation of the cell media, thereby reducing potential drifts in 
current due to a false increase in concentration. Secondly, the lid is porous allowing for 
gaseous exchange, thereby maintaining the cell media pH. A pipette lid is also inserted 
through the cork, to assist gaseous exchange and allow for an entry port for the addition of 
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aliquots of glutamate. Thirdly, the cork lids allow for the real time analysis of multiple 
wells simultaneously, as they fit securely into the six well plates. Finally, it reduces the 
likelihood of shorting as the connections to the potentiostat are separated from the cell 
media solution.  
 
Figure 4-9: Image depicting the experimental setup used for the real time studies.  
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Figure 4-10: Typical real time amperometric response produced by glutamate released 
from HepG2s cells exposed to 10mM of paracetamol over 8 hours. 3600s = 1 hour. 
 
Figure 4-11: Typical real time amperometric response produced by glutamate released 
from HepG2s cells exposed to 5mM of paracetamol over 8 hours. 
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Figure 4-12: Typical real time amperometric response produced by glutamate released 
from HepG2s cells exposed to 5mM of paracetamol over 8 hours. 
The resulting typical real time dose response plots for each concentration is shown in Figure 
4-10, Figure 4-11 and Figure 4-12. The amperometric responses demonstrate the ability of 
the microband biosensor to monitor the release of glutamate from the HepG2 cells as a 
result of paracetamol induced toxicity. As a result, the observation of early metabolic 
reactions, cellular recovery from the initial exposure to paracetamol, and the rate at which 
cellular damage occurs, is possible.  
It should be noted that the currents generated by the biosensor, while monitoring the 
HepG2, cells in real time exceeds the current corresponding to the Km attained in non-
treated culture media. This observation is probably as the result of the release of additional 
NAD+ from the HepG2 cells, as well as additional glutamate, resulting in higher currents. 
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Figure 4-13: Amperogram illustrating additions of 200µM glutamate and 2mM NAD+ 
into a cell containing 6mLs of cell media, in the absence of HepG2 cells.  
In order to provide evidence for this observation, a study was performed with the biosensor 
in cell media containing glutamate without cells, but with the addition of NAD+ solution. 
Figure 4-11 illustrates the current generated by an initial addition of 200µM of glutamate 
(42nA) to the cell-free medium, followed by the addition of 2mM NAD+ solution, clearly, a 
large increase in current occurs following NAD+ addition. A further two additions of 
200µM glutamate were made which resulted in higher currents being generated than for the 
initial addition of NAD+ (265nA and 270nA respectively). This study suggests that the 
NAD+ released by the cells into free solution results in the increase in current beyond that 
previously observed with the end-point assay.  
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An explanation for this effect is as follows. Paracetamol (I) in sub-lethal concentrations is 
typically processed in the liver through Phase I and Phase II metabolism by CYP450 
enzymes, whereby paracetamol is converted to n-acetyl-p-benzoquinone imine (NAPQI) 
(II). Subsequently, glutathione conjugates the NAPQI to form a non-harmful product (III) 
under small doses, however, at higher concentrations the glutathione is unable to regenerate 
at a sufficient rapid rate to sequester the NAPQI [21]. The excess NAPQI subsequently 
binds to membrane proteins (IV) [22][23], resulting in hepatic necrosis, which leads to the 
rupture of the cell membrane and release of its contents.  
 
Figure 4-14: Mechanism of Action for Paracetamol and the conjugation of NAPQI.  
Glutamate dehydrogenase is found in high concentrations in rat liver [24] and adult human 
liver [25] due to its association with amino acid metabolism. As a result, increased 
concentrations of paracetamol are likely to lead to increased hepatic necrosis, subsequently 
leading to an increase in glutamate concentration, which together with glutamate 
dehydrogenase and NAD+ are released from the cells. The currents generated scale 
accordingly with the increasing concentrations of paracetamol utilised, highlighting that the 
biosensor is continuously monitoring changes in glutamate released by the cells.  
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Figure 4-15:  Bar chart illustrating the currents  generated as a result of glutamate 
released by the HepG2 cells after 8 hours of incubation in the presence of various 
concentrations of paracetamol. Std deviations based on n = 3.  
Figure 4-15 illustrates the currents generated with respect to the concentration of 
paracetamol. The standard deviations shown are as follows; 1mM (coefficient of variation 
(CoV): 3.3%), 5mM (CoV: 9.056%) and 10mM (CoV: 13.18%). It should be mentioned 
that the effect of paracetamol monitored in real time agrees closely with the end point assay 
described in section 4.3.5. 
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4.5. Conclusions 
Based on the findings presented in this chapter, it appears that the application of a 
reagentless glutamate biosensor to both real-time monitoring and post-exposure of 
mammalian cells in response to toxic challenge from various concentrations of paracetamol 
can provide a means of assessing metabolic activity.  
In repeat studies, the toxicity induced release of glutamate from the HepG2 cells resulted in 
currents which corresponded with the concentrations of paracetamol utilised. By 
standardising the experimental setup (37ºC in an incubator with a 5% CO2 atmosphere, all 
studies carried out in cell media) reduced the potential for error by maintaining a favourable 
environment for the cell media/cells. This ensures all metabolic effects are caused by the 
addition of paracetamol.  
Electrochemical microband biosensor monitoring in real time for metabolic events holds 
great potential for further development. The simple drop coating fabrication procedure and 
the simple cutting technique to fabricate the microband biosensor, could be a potential 
platform for developing other microband biosensors based on dehydrogenase enzymes. 
Future studies towards incorporating a series of reagentless microband biosensors based on 
screen printed carbon electrodes into a multi-well array system for the simultaneous 
monitoring of multiple analytes released from mammalian cells in response to toxic 
challenge for the reduction or replacement of animal testing is currently ongoing.  
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5.1. Introduction 
In chapter 3 we have reported on an approach to glutamate biosensor development, based 
on a screen–printed biosensor incorporating a redox mediator and glutamate dehydrogenase 
(GLDH). In that approach the required enzyme cofactor, nicotinamide adenine dinucleotide 
(NAD+), was added into the analyte solution containing glutamate; the disposable biosensor 
was successfully applied to the analysis of serum and stock cubes [1]. While successful, the 
main drawback of this approach for a commercial biosensor is the requirement to add the 
cofactor into the sample solution. In chapter 4, a reagentless microband biosensor was 
fabricated and applied to both post-exposure and real time toxicity studies. The fabrication 
process consisted of utilising CHIT, NAD+ and GLDH, dropcoated onto the surface of the 
working electrode of the MB-SPCE. Once dried, the surface was covered with insulating 
tape and the microband was defined by cutting through the WE with scissors. In this 
chapter, the fabrication of a conventional sized biosensor utilising a layer-by-layer drop 
coating procedure is described. 
Carbon nanotubes (CNTs) are renowned for their unique electronic and mechanical 
properties [2]. They possess a high active surface area, excellent biocompatibility [3] and 
the ability to facilitate redox reactions with fast electron–transfer rates [4]. These abilities 
have popularised CNTs in the development of electrochemical biosensors.  
Two forms of CNT exist; single walled CNT (SWCNTs) and multi–walled CNT 
(MWCNTs). SWCNTs possess a singular graphite sheet rolled into a tube to produce a 
cylindrical nanostructure, whereas MWCNT consist of several shells of cylindrical tubes. 
Integration of redox dyes such as Meldola’s Blue (MB) into MWCNT matrices, has been 
previously demonstrated with well–defined voltammetric responses [5]–[7]. It should be 
mentioned that the electrocatalyst MB greatly reduces the over-potential for the oxidation of 
NADH [8]. 
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The low solubility of unmodified MWCNTs leads to poor homogenous dispersion, thus in 
the present study the MWCNTs were suspended in a solution containing chitosan (CHIT). 
CHIT is a natural polysaccharide derived from crustaceans, which enhances enzyme 
stability and possesses good film forming properties [9], [10]. The dispersion of CNTs was 
possible due to the low pH required to solubilise the CHIT (pH < 3.0) [11], which was 
achieved using HCl. It was reported that the dispersion of MWCNTs in CHIT/HCl 
compared with other solvents gave the smallest particle sizes and resulted in the formation 
of a greater surface area without the need for functionalization.  
It has previously been reported that NAD+ was readily integrated into a glucose 
dehydrogenase biosensor and did not leach from the MWCNT matrix when coated onto the 
surface of a glassy carbon electrode [12]. This was achieved utilising a layer-by-layer 
assembly procedure. Other researchers have reported on the layer-by-layer immobilisation 
method using modified CNTs to immobilise glutamate oxidase [13], [14] and horse radish 
peroxidase [15]. This procedure is regarded as a simple, inexpensive and highly versatile 
method for the incorporation of components into film structures [16].  The advantages of a  
reagentless device fabricated using this approach is that it leads to a low cost biosensor 
which is convenient to use as no additional cofactor is required to be added to the sample 
solution [17], [18]. 
This chapter describes the steps involved in the layer-by-layer development of a fully 
reagentless amperometric biosensor for glutamate. The strategy employed to achieve this 
goal has involved the integration of the biological components (enzyme and cofactor) with 
multi–walled carbon nanotubes (MWCNTs) on the surface of a Meldola’s Blue screen–
printed carbon electrode (MB–SPCE). The biosensor has been applied to the determination 
of glutamate in serum sample and stock cubes.  
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Based on the literature, it is believed that this is the first report on the development and 
application of a reagentless amperometric glutamate biosensor, based on GLDH and NAD+ 
integrated with a disposable screen-printed electrode.  
5.2. Materials and Methods 
5.2.1. Chemicals and reagents 
All chemicals were of analytical grade, purchased from Sigma Aldrich, UK, except 
glutamate dehydrogenase (CAT: 10197734001) which was purchased from Roche, UK. The 
75 mM phosphate buffer (PB) was prepared by combining appropriate volumes of tri–
sodium phosphate dodecahydrate, sodium dihydrogen orthophosphate dihydrate and 
disodium hydrogen orthophosphate anhydrous solutions to yield the desired pH. Glutamate 
and NADH/NAD+ solutions were dissolved directly in 75 mM PB. Chitosan (CHIT) was 
dissolved in 0.05 M HCl (pH < 3.0) to produce a 0.05% solution following up to 10 minutes 
sonication. The multi-walled carbon nanotubes (MWCNT)/CHIT solution was prepared by 
mixing 0.6 mg of MWCNT into 300 µL solution of 0.05% of CHIT, with 15 minutes of 
sonication and stirring for 24 hours. Meldola’s Blue (MB) in solution was prepared by 
dissolving the appropriate weight in distilled water. Fetal bovine serum (FBS) (South 
American Origin, CAT: S1810–500) obtained from Labtech Int. Ltd, was used for serum 
analysis. Food samples (Beef OXO cubes) were obtained from a local supermarket.   
5.2.2. Apparatus 
All electrochemical experiments were conducted with a three–electrode system consisting 
of a carbon working electrode containing MB, (MB–SPCE, Gwent Electronic Materials 
Ltd; Ink Code: C2030519P5), a Ag/AgCl reference electrode (GEM Product Code 
C61003P7); both printed onto PVC, and a separate Pt counter electrode. The area of the 
working electrode was defined using insulating tape, into a 3 x 3 mm square area. The 
electrodes were then connected to the potentiostat using gold clips. Solutions, when 
required, were stirred using a circular magnetic stirring disk and stirrer (IKA® C–MAG HS 
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IKAMAG, Germany) at a uniform rate. A µAutolab II electrochemical analyser with 
general purpose electrochemical software GPES 4.9 was used to acquire data and 
experimentally control the voltage applied to the SPCE in the 10 ml electrochemical cell 
which was used for hydrodynamic voltammetry. An AMEL Model 466 polarographic 
analyser combined with a GOULD BS–271 chart recorder was used for all amperometric 
studies. Measurement and monitoring of the pH was conducted with a Fisherbrand Hydrus 
400 pH meter (Orion Research Inc., USA). Sonications were performed with a Devon 
FS100 sonicator (Ultrasonics, Hove, Sussex, UK). 
5.3. Procedures 
5.3.1. Fabrication of the reagentless MWCNT–CHIT–MB/GLDH–NAD+–
CHIT/MWCNT–CHIT biosensor.  
Fabrication was carried out using a layer-by-layer approach to produce a total of three 
layers. Solutions were drop-coated onto the 3mm2 carbon working electrode.  Initial studies 
were performed to deduce the composition of layers 1 and 3. Figure 5-1 represents the 
layer-by-layer biosensor.  
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Figure 5-1: A schematic diagram displaying the layer-by-layer drop coating 
fabrication procedure used to construct the reagentless glutamate biosensor, based on 
a MB-SPCE electrode. 
Layer 1 was formed by drop coating a 10µL mixture of MWCNTs suspended in a solution 
containing 0.05% CHIT in a 0.05M HCl solution. This layer was allowed to partially dry at 
4°C under vacuum for 10 minutes.  
Layer 2 was optimised by carrying out amperometric studies with biosensors constructed 
using different mass combinations of CHIT, NAD+ with a fixed GLDH content of 27U 
(Table 1). This layer was allowed to dry at 4°C under vacuum for 3 hours. 
Layer 3 was formed in the same manner as Layer 1. This layer was allowed to dry at 4°C 
under vacuum for 2 hours.  
A further study into the effect of including additional MB was also performed. This was 
done by mixing in 1 µL of 0.01M MB in H2O with the MWCNTs in layers 1 and 3. For 
layer 2, an additional 1 µL of 0.01M MB in H2O was deposited at the composite surface. 
Biosensors were stored under a vacuum at 4°C when not in use. A photograph of the final 
biosensor is provided (Figure 5-2).  
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Figure 5-2: Photograph of the final complete biosensors with insulating tape attached.  
5.3.2. Hydrodynamic Voltammetry 
Hydrodynamic voltammetry was performed using the complete biosensor with 400 µM of 
glutamate,  in 0.75 mM phosphate buffer (pH 7.0) containing 50mM NaCl , in order to 
enzymatically generate NADH so as to establish the optimum operating potential for the 
amperometric determination of glutamate in food and serum samples. An initial potential of   
-120mV was applied to the biosensor and the resulting steady state current was measured; 
the potential was then changed to -115mV and again a steady state current was measured. 
The procedure was continued by changing the potential by 50mV steps to a potential of 
+100mV, with subsequent steps increasing by 25mV up to a final potential of +150mV. The 
steady state currents were measured at each potential, then a hydrodynamic voltammogram 
was constructed by plotting the steady state currents against the corresponding potentials.   
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5.3.3. Optimisation studies with the proposed biosensor using amperometry in 
stirred solution. 
All amperometric measurements were performed with stirred 10mL solutions of 75mM PB 
pH 7.0 with 50mM NaCl (PBS), using an applied potential of +0.1 V vs. Ag/AgCl. In order 
to optimise the conditions the biosensor was immersed in a stirred buffer solution, the 
potential applied and sufficient time was allowed for a steady–state current to be obtained. 
The optimisation of each component in layer 2 was performed by measuring the 
amperometric response to the additions of glutamate over the concentration range of 7.5 µM 
to 100 µM glutamate. The variations in the quantities of the components are shown in Table 
5-1.  
GLDH (Units) NAD
+
 (µg) CHIT (µg) 
27 13.5 5 
27 27 5 
27 54 5 
27 106 5 
27 214 5 
27 106 5 
27 106 10 
27 106 15 
27 106 20 
Table 5-1: This table displays the combination of components found in layer 2. 
After the optimisation of the NAD+ and CHIT components, the integration of additional 
0.01M Meldola’s Blue into each layer of the biosensor was investigated by amperometry. 
Following optimisation of the individual biosensor components, studies into the effects of 
temperature and pH on the biosensor response were investigated. Optimum pH was 
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determined by carrying out calibration studies over the pH range 5 – 9 (Figure 5-3). A 
separate study was conducted to determine the optimum temperature (Figure 5-4). The 
temperature was varied over the range 25 – 40°C with the pH fixed at 7.  
 
Figure 5-3: pH study conducted over the range of pH 5 to 9. n = 3 
 
Figure 5-4: Temperature study conducted over the range of 25 to 40°C.  n = 3 
 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
5 6 7 8 9
S
e
n
s
it
iv
it
y
 (
n
A
/µ
A
) 
pH 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
25 30 35 40
S
e
n
s
it
iv
it
y
 (
n
A
/µ
M
) 
Temperature °C 
Chapter Five 
144 
 
5.3.4. Application of optimised amperometric biosensor to the determination of 
glutamate in food.  
An OXO cube was prepared by dissolving one cube in 50 mL of phosphate buffer and 
sonicating for 15 minutes. The endogenous concentration of MSG was determined by using 
the method of standard addition. An initial 5µl volume of the dissolved OXO cube was 
added to the stirred buffered solution (10 mL) in the voltammetric cell containing the 
biosensor, operated at +0.1 V (vs. Ag/AgCl) with subsequent standard additions of 3 µL of 
25 mM glutamate. 
The reproducibility of the biosensor assay for MSG analysis in OXO cubes was determined 
by repeating the whole procedure five times with five individual biosensors.  
5.3.5. Application of optimised amperometric biosensor to the determination of 
glutamate in serum. 
The endogenous glutamate concentration of serum was determined by injecting an initial 
volume of 150 µL of serum into 9.85mL of buffer solution. Amperometry in stirred solution 
using an applied potential of +0.1V vs. (Ag/AgCl) was conducted with the serum solution. 
This was followed by additions of 3 µL aliquots of 25 mM standard glutamate solution to 
the voltammetric cell. The currents resulting from the enzymatic generation of NADH were 
used to construct standard addition plots, from which the endogenous concentration of 
glutamate was determined (n = 5). The reproducibility of the biosensor measurement was 
deduced by repeating the studies five times on a freshly diluted solution of the same serum 
with a fresh biosensor for each measurement. 
The procedure was repeated using 50µL of serum spiked with 1.5 mM glutamate (n = 5) to 
determine to the recovery of the assay.  
Due to the complex nature of the samples investigated, interferences such as ascorbic acid, 
sugars and other amino acids may be present. The possible effects of naturally occurring 
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interferences from serum and OXO cubes were established using a dummy BSA biosensor. 
A dummy biosensor was constructed by drop coating the equivalent weight of the enzyme 
with BSA; however, no signals due to interfering substances were detected.  
5.4. Results and Discussion 
5.4.1. Characterisation of the biosensor using scanning electron microcroscopy 
(SEM) and amperometry 
Figure 5-5 shows SEM images of the different layers deposited on top of the original 
Meldola’s Blue SPCE (MB-SPCE). The only treatment of the biosensor specimens was a 
drying procedure.  
 
Figure 5-5: SEM imaging of each individual layer of the reagentless biosensor. The 
scale is the same for all SEM images. 
Layer 1 (MWCNTs-CHIT-MB) is a porous open structure which shows the MWCNTs-
CHIT deposited on the surface. The MB particles may be absorbed on both the exterior and 
interior of the MWCNTs.  
Layer 2 appears to consist of a more cohesive film covering the added components 
(GLDH-NAD+-CHIT-MB). The possibility of utilising this structure as a biosensor for 
glutamate was investigated, however, the amperograms did not display steady state 
currents. From this we deduced that the cofactor (NAD+) and possibly the enzyme (GLDH) 
were not retained behind the film. This suggests that the film may actually be porous and 
that in solution the pores increase in size with egress of the biocomponents.  
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Layer 3 shows a more compact structure and the underlying biosensor components are less 
visible than in layer 2. The biosensor comprising all 3 layers produced steady state 
responses to the addition of glutamate, indicating successful immbolisation of all the 
components.  
5.4.2. Hydrodynamic Voltammetry 
Hydrodynamic voltammetry was performed using the reagentless biosensor with 400 µM of 
glutamate in 0.75mM phosphate buffer (pH 7.0) containing 50mM NaCl. The optimum 
potential was considered to be +0.1V vs. Ag/AgCl (Figure 5-6) as this potential was 
situated on the plateau of the voltammetric wave.   
 
Figure 5-6: Hydrodynamic voltammograms obtained using MB-SPCE/MWCNT-
CHIT-MB/GLDH-NAD+-CHIT-MB/MWCNT-CHIT-MB biosensor in the presence of 
400µM glutamate in 75mM phosphate buffer (pH 7.0) containing 50 mM NaCl. 
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5.4.3. Optimisation Studies 
GLDH 
(Units) 
NAD
+
 (µg) CHIT (µg) Linear 
Range (µM) 
Sensitivity 
(nA/µM) 
27 13.5 5 25 – 50  0.035 
27 27 5 25 – 100 0.230 
27 54 5 25 – 75 0.238 
27 106 5 25 – 100 0.307 
27 214 5 25 – 50 0.238 
27 106 5 25 – 100 0.305 
27 106 10 7.5 – 105 0.315 
27 106 15 25 – 50  0.261 
27 106 20 Steady states 
not achieved. 
N/A 
Table 5-2: Performance characteristics of the glutamate biosensor fabricated with 
different masses of NAD
+
 and CHIT using a fixed quantity of GLDH. 
Table 5-2 displays that the best performance for the glutamate biosensor was achieved with 
106 µg NAD+ and 10 µg of CHIT, together with 27U of GLDH in layer 2, in the absence of 
MB.  
It has been noted by [19], that with increasing concentrations of CHIT, the particle size of 
untreated MWCNT’s in aqueous solution is increased; consequently the larger particle size 
leads to increasingly entangled molecules of CNT/CHIT resulting in higher visocities. This 
change in visoscity would lead to a smaller diffusion coefficient, therefore leading to a 
decrease in the signal. This might explain why loadings of 15µg and 20µg resulted in less 
sensitivity than 10µg in the present study. This also suggests that 5µg may not have 
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sufficiently bound the biological components, in comparison to 10µg of CHIT. 
Consequently, a CHIT loading of 10µg was selected for further studies.  
In order to asses the possibility of enchancing the effectiveness of the electron shuttling 
through the MWCNTs to the underlying MB electrode, the effect of adding  additional MB 
into these layers was investigated. It was found that the sensitivity was increased from 
0.315 nA/µM to 0.396 nA/µM and the linear range was unaltered. Consequently MB was 
incorporated into all layers of the biosensor for all further studies. 
5.4.4. Linear Range, Sensitivity, Detection Limit and Lifetime of Biosensor  
Figure 5-7A, shows a typical amperogram obtained with the optimised biosensor for 
different concentrations of glutamate. The resulting calibration plots (Appendix Figure 1) 
are linear over the range 7.5 – 105µM, the first calibration plot depicts Fig 5A; the detection 
limit was 3µM (based on n = 5, the coefficient of variation (CV) was 8.5%), based on three 
times the signal to noise, and the sensitivity was 0.39 nA/µM (based on n =5, the CV was 
6.37%). It should be noted that the biosensor possesses sensitivity relative to surface area of 
4.3µA/mM/cm2. This behaviour demonstrates the possibility of applying this device to food 
and biological samples.  
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Figure 5-7 A) Amperogram conducted with the proposed final biosensor. Each arrow 
represents an injection of 3µL of 25mM glutamate in a 10mL stirred solution 
containing supporting electrolyte; 75mM, PB (pH 7.0), with 50mM NaCl at an applied 
potential of +0.1V vs. Ag/AgCl 
The life time of the biosensor in continuous operation is 2 hours, whilst the shelf lifetime is 
at least 2 weeks without any change in sensitivity (Appendix Figure 2). For the latter study, 
biosensors were stored in a desiccator which was stored in a fridge at 4°C. It should be 
mentioned that biosensors based on the cofactor NAD+ can be readily stabilised for over six 
months using commercially available enzyme stabilisers [20]. The life time of the biosensor 
was determined by calibration studies with known additions of glutamate in buffer (pH 7, 
35°C). The sensitivity was then determined based on the slope of the subsequent calibration 
plots (n = 3). 
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5.4.5. Optimisation of Temperature and pH 
The optimum pH was determined by carrying out calibration studies over the pH range 5 – 
9 at a temperature of 25°C. The optimum pH was determined to be pH 7 as biosensors 
achieved the greatest sensitivity at this pH. A neutral pH also ensures that further studies 
investigating food and serum will not require the pH to be changed to achieve maximum 
sensitivity, thereby reducing sample preparation steps. A separate study was carried out to 
determine the optimum temperature. The temperature was varied over the range 25 – 40°C 
with the pH fixed at 7. The optimum temperature was determined to be 35°C. 
5.4.6. Application of the optimum amperometric biosensor (MWCNT–CHIT–
MB/GLDH–NAD–CHIT–MB/MWCNT–CHIT–MB) to the determination of 
glutamate in unspiked food.  
Many food products are known to contain MSG as a flavour enhancer, therefore, we 
decided to apply our new reagentless biosensor to determine glutamate in a known brand of 
beef stock cube.  
Standard addition was conducted by dissolving one OXO cube (5.9 g mass) in 50ml of PB 
and sonicating for 15 minutes until fully dissolved. Five replicate aliquots from this solution 
were analysed using fresh reagentless biosensors for each measurement. The determination 
was performed by adding an aliquot of PBS (9.95 mL) to the voltammetric cell, establishing 
a steady state current, and then injecting a 5µL volume of the OXO cube/PB solution into 
the cell. Sequential 3µL injections of 25 mM glutamate were then added to the cell, 
standard addition plots were constructed and from these the endogenous glutamate 
concentration was determined (n = 5). The mean quantity of glutamate recovered in 
unspiked OXO Cubes was 90.6 mg/g, with a CV of 7.52%; results are shown in Table 5-3. 
A typical amperogram obtained from the analysis of an OXO cube utilising the reagentless 
biosensor is shown in Figure 5-8. 
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OXO Cube 
Sample 
Quantity of 
Glutamate Recovered 
(mg/g) 
 
 Unspiked Foetal 
Bovine Serum 
Sample 
Concentration of 
Glutamate 
Detected (mM) 
 
1 92.33  1 1.45 
2 91.48  2 1.60 
3 96.73  3 1.33 
4 94.83  4 1.30 
5 77.47 
 
 5 1.51 
Mean (mg/g) 90.56  Mean (mM) 1.44 
Std Dev 6.81  Std Dev 0.12 
CV (%) 7.52  Cov (%) 8.54 
Table 5-3: Quantity of glutamate determined in an unspiked beef OXO cube and 
in unspiked foetal bovine serum. 
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Figure 5-8: Amperogram displaying the determination by standard addition of an 
unspiked OXO cube, utilising the proposed final biosensor. 75mM, PB (pH 7.0), 
with 50mM NaCl at an applied potential of +0.1V vs. Ag/AgCl. 
The average percentage of glutamate was calculated relative to the mass of an OXO cube 
and was found to be 18.1% (± 1.36%, n = 5). This compares favourably with a previously 
published value for MSG content in OXO cubes [1]. The quantity of glutamate recovered 
from the stock cube compares favourably with levels calculated with an optical biosensor, 
validated with HPLC [21] and utilising high performance thin layer chromatography [22]. 
The optical biosensor and HPLC analysis determined an L-glutamate level of 18.29% (± 
0.66%) and 17.70% (± 0.34%) based on n = 3, whilst the high performance thin layer 
chromatography technique determined a level of 133.50 mg/g (± 0.84%, n = 3). These 
values compare favourably to the values we have determined utilising the reagentless 
biosensor.  
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5.4.7. Application of the optimum amperometric biosensor (MWCNT–CHIT–
MB/GLDH–NAD–CHIT–MB/MWCNT–CHIT–MB) to the determination of 
glutamate in both unspiked and spiked serum. 
Amperometry, in conjunction with standard addition, was used to determine the endogenous 
levels of glutamate and the recovery for serum spiked with additional glutamate. The 
replicate serum samples were analysed using a fresh biosensor for each measurement. A 
typical amperogram obtained from the analysis of unspiked serum utilising the reagentless 
biosensor is shown in Figure 5-9 in the supplementary material. 
 
Figure 5-9: Amperogram displaying the determination by standard addition of an 
unspiked serum, utilising the proposed final biosensor. 75mM, PB (pH 7.0), with 
50mM NaCl at an applied potential of +0.1V vs. Ag/AgCl. 
The data obtained on serum samples using the glutamate biosensor are shown in Table 3. 
The mean endogenous level of glutamate detected was 1.44 mM for the unspiked samples. 
The coefficient of variation was 8.54% for the five individual samples. This value is 
comparable to our previous publication [1] in which we report a value of 1.68 mM. It is 
worth noting this also compares favourably to a value discovered by a bioluminescence 
method [23]. 
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The biosensors were then used to determine glutamate in spiked serum by fortifying with 
1.50 mM of glutamate. The results are shown in Table 5-4. The mean recovery (n = 5) was 
104% with a CV of 2.91%. 
Sample Fortified 
Glutamate 
(mM) 
Endogenous 
Concentration 
(mM) 
Concentration of 
Glutamate Detected 
(mM) 
 
Recovery 
(%) 
1 1.50 1.44 2.96 101 
2 1.50 1.44 3.01 105 
3 1.50 1.44 3.02 105 
4 1.50 1.44 2.97 102 
5 1.50 1.44 3.07 109 
     
Mean recovery (%) 104    
Std Dev 3    
Cov (%) 2.91    
 
Table 5-4: Recovery of glutamate detected in spiked serum fortified with 
additional glutamate. 
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5.5. Conclusion 
This chapter has described the development of a reagentless amperometric glutamate 
biosensor. This was achieved by incorporating the biocomponents using a layer-by-layer 
procedure involving chitosan and MWCNTs. The device produced well defined steady state 
currents over extended operating times indicating that the bio-components are securely 
immobilised onto the base transducer.  
The reagentless glutamate biosensor, fabricated in this study, is to date the first of its kind; 
our biosensor detection limit compares favourably to those previously reported for non-
reagentless glutamate sensors. The limit of detection of our biosensor  is  3 µM, whereas 
detection limits of [24]–[33], respectively.  
The device and its components have been fully optimised to produce a reproducible 
reagentless biosensor which has been applied to the analysis of glutamate in clinical and 
food samples. Notably, the samples required no pre-treatment, other than dilution. The 
content of glutamate determined in OXO cubes and in serum compares favourably to that 
determined with our previous glutamate biosensor [1].  
This novel layer-by-layer approach to biosensor fabrication may hold promise as a generic 
platform for future biosensors based on dehydrogenase systems.  
It should be mentioned that the analysis of neuronal cells for changes in glutamate flux is of 
significant biomedical interest. High levels of glutamate leads to excitotoxicity, which is 
associated with diseases previously mentioned in the introduction. For potential future 
studies and applications, it is of value to consider how our biosensor compares to previously 
reported sensors which determine neuronal glutamate.  
Previously reported microelectrodes have been used to measure glutamate in vivo in rodent 
studies; these were fabricated by coating microelectrodes with glutamate oxidase [34]–[41]. 
These required high operating potentials (+600 - 700mV vs. Ag/AgCl), as the detection 
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system involved the measurement of hydrogen peroxide. High operating potentials can lead 
to the oxidisation of interferences such as ascorbic acid, which can interfere the 
measurement of glutamate. It is worth noting that Oldenziel et al., 2006, utilised a lower 
operating potential of +150mV vs. Ag/AgCl, by utilising the electron mediator horseradish 
peroxidase; which increased the complexity of biosensor fabrication.  
Microelectrodes coated with glutamate dehydrogenase are uncommon; this is likely due to 
the requirement of integrating the cofactor NAD+ onto the surface of the microelectrode 
without leeching, as mentioned previously. By miniaturizing our reagentless biosensor, the 
lower operating potential required to generate an analytical response would prove beneficial 
for the analysis of glutamate in real time, in neuronal cells. Our approach would negate the 
requirement for additional enzymes or use of charged membranes such as Nafion, to block 
out potential interferences. It should be feasible to incorporate the approach described in 
this chapter into an implantable system by dip coating a carbon fibre electrode (10µM 
diameter) into the formulation described in this chapter.  
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6. Conclusions 
6.1. Fabrication of a Non-Reagentless Glutamate Biosensor 
As described in Chapter 3, the non-reagentless glutamate biosensor based on MB-SPCE 
was successfully fabricated by drop coating the biopolymer CHIT, followed by GLDH, 
onto the surface of the working electrode. The utilisation of the electrocatalyst MB 
transducer, present within the ink, greatly reduced the potential required to 
electrocatalytically oxidize the NADH, in comparison to a plain carbon screen printed 
electrode. As a result, a low applied potential of only +100mV (vs. Ag/AgCl) resulted in the 
maximum response; this potential was ascertained using hydrodynamic voltammetry in the 
presence of NADH and was subsequently used for all amperometric studies. The low 
applied potential and the presence of CHIT on the WE, reduced the likelihood of 
interferences directly oxidising at the electrode surface resulting in unwanted current 
responses. The use of dummy biosensors fabricated using BSA measured any response 
generated by interfering compounds present in OXO cubes and serum such as ascorbic acid.  
The biopolymer CHIT was used to successfully immobilize GLDH onto the surface of the 
transducer, without denaturing the enzyme and successfully retaining the enzyme within the 
biosensor matrix without leeching into free solution. This ensured that during amperometric 
studies, steady state currents were achieved.  
The operating conditions such as the temperature and pH were optimised. The optimal 
conditions were 35ºC and pH 7 respectively. These conditions also ensured that a minimal 
amount of sample preparation was required to analyse both serum and food.  
The amperometric biosensor was successfully applied to the determination of endogenous 
concentrations of glutamate present in both OXO cube and serum solutions. Sample 
preparations consisted of simply diluting the serum in phosphate buffer, whilst the OXO 
cube was dissolved in 50mLs of phosphate buffer and further diluted. Subsequent recovery 
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studies yielded high recoveries with low coefficients of variation, indicating that the 
biosensor fabrication technique was rapid, convenient and resulted in highly reproducible 
and simple to fabricate.  
In relation to the objectives stated in Chapter 1, Section 1.8, we have successfully 
completed the following objectives in this section;  
 Development of a glutamate biosensor utilising glutamate dehydrogenase, NAD+ 
based on Meldola’s Blue screen printed carbon electrodes.  
 Immobilisation of the enzyme glutamate dehydrogenase to the surface of the 
working electrode the MB-SPCE to produce glutamate biosensors. 
 Optimisation of the biosensor working conditions and the determination of the 
glutamate content of food and clinical samples utilising standard addition.  
The limitation of the biosensor is the requirement of the cofactor to be present in free 
solution, however, immobilization of the cofactor was a novel aspect of later studies and is 
demonstrated within Chapters 4 and 5. In comparison to previously reported glutamate 
biosensors, the LOD compares favourably to other glutamate dehydrogenase biosensors and 
possesses a superior response time of 2s.  
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6.2. Fabrication of a Reagentless Microband Glutamate Biosensor 
The biosensor described in Chapter 3 was further developed in order to fully integrate the 
cofactor NAD+ onto the surface of the electrode in order to produce a reagentless device. 
The main advantage of a reagentless device is that this simplifies the fabrication process 
and utilisation of the device as all components of are immobilized on the surface. 
Reagentless devices are also of commercial interest. In the real time analysis of cells, in 
response to toxic effect, this is vital as additional cofactors added into free solution may 
disrupt the cells or reduce sterility.  
The fabrication process was relatively simple and similar to that described in Chapter 3. The 
enzyme and co-factor were immobilised onto the surface of the MB-SPCE by drop-coating 
a mixture of GLDH-NAD+-CHIT. Once dried the working electrode was covered with 
insulating tape and cut through laterally in order to define the microband edge. It is likely 
that the presence of the insulating tape and the absence of stirring the solution ensured that 
the biosensor components were retained on the surface of the electrode. The biosensor 
demonstrated a longer linear range and increased sensitivity in cell media compared with a 
phosphate buffer. This is likely due to enzyme promoters present in the cell media solution 
that may be enhancing the enzyme activity. 
The biosensor was first successfully applied to toxicity testing using an end-point assay; 
whereby standard addition was used to quantify glutamate in cell media which had been in 
the presence of HepG2 cells exposed to various concentrations of paracetamol. Secondly, it 
was successfully applied to real time studies, whereby the glutamate released from cells was 
monitored over 8 hours. The results for both methods suggested that with increasing 
concentrations of paracetamol, increased concentrations of glutamate were released by 
cells, suggesting greater levels of toxicity.  
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In relation to the objectives stated in Chapter 1, Section 1.8, we have successfully 
completed the following objectives in this section;  
 Further development of the biosensor to immobilize the cofactor NAD+ onto the 
surface of the screen-printed carbon electrode.  
 The miniaturisation of the biosensor in order to develop micro-band biosensors for 
the determination of glutamate released by HepG2 cells in response to toxic 
challenge.  
 Development of an electrode holder to simultaneously immerse the biosensor within 
the cell media solution for the interrogation of the cells, whilst reducing evaporation 
and allowing for gas exchange between the cell media and atmosphere.  
6.3. Fabrication of a Reagentless Macro Glutamate Biosensor utilising Carbon 
Nanotubes 
In order to fabricate a conventional (macro) sized reagentless biosensors, the enzyme and 
cofactor must be fully immobilized to the surface of the biosensor, without leeching into 
free solution. This was achieved by utilising a mixture of multi-walled carbon nanotubes 
and chitosan, drop coated in a layer-by-layer procedure. The presence of additional water-
based Meldola’s Blue throughout the reaction layer resulted in an increase in sensitivity, 
which coupled with the MWCNT’s, is considered to increase the  electron shuttling rate 
from the outer layers of the biosensor, to the working electrode.  
Although the layer-by-layer procedure is a little more complex, than that described earlier, 
the resulting biosensor produces steady state currents, over prolonged analysis times, 
indicating that all bio-components are strongly retained on the transducer surface. 
Consequently, this novel approach could be adapted to the fabrication of biosensors for the 
measurement of many different analytes. 
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The shelf life time of the proposed biosensor was at least 2 weeks without any change in 
sensitivity. This could be improved by utilising commercially available enzyme stabilisers.  
In relation to the objectives stated in Chapter 1, Section 1.8, we have successfully 
completed the following objectives in this section;  
 Development of a conventional sized reagentless glutamate biosensor.  
 Optimisation of the biosensor components and working conditions, in order to apply 
the reagentless biosensor to the determination of glutamate in complex samples.  
6.4. Overall conclusions  
Enzyme-based biosensors for the determination of glutamate have been developed utilising 
three different fabrication techniques and for two different electrode dimensions. Non-
reagentless and reagentless devices have also been developed. It has been shown that the 
biosensors in an amperometric assay, can be applied to the determination of glutamate in 
serum and food samples. Recovery studies were also carried out it was demonstrated that 
with high recovery values and low coefficients of variation could be obtained.  
A biosensor was successfully applied to toxicity testing by incorporating the device into 
wells containing live HepG2 cells for continuous measurements. The same biosensor could 
also be used for toxicity testing using an end-point assay.  
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6.5. Future Studies 
In order to increase the operating time for continuous monitoring of the glutamate released 
by cells, several modifications to the fabrication method could be investigated. The sterility 
of the biosensors and the culture medium containing cells could be improved. The biosensor 
could be sterilised by gamma radiation, without significantly affecting the enzyme, cofactor 
and the electrode material. Autoclaving is also possible but could result in the denaturing of 
the enzyme, cofactor and possibly damage the electrode material. The electrode holder, in 
addition to being cleaned by ethanol, could also be exposed to gamma radiation. By 
sterilising these components, this would increase the duration over which the real time 
studies can take place in the absence of bacterial or fungal infection. The microband 
biosensor could be further developed and integrated into a biosensor array for multiple 
analyte monitoring in real time. Multiple human cells lines could also be utilised in a multi-
well format order to replicate in vivo responses in vitro. Additional applications include 
environmental toxicity monitoring and food safety.  
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Appendix Figure 1) Five typical standard addition calibration plots obtained with five 
individual MWCNT-CHIT-GLDH-NAD+-MB-SPCE.   
 
Appendix Figure 2) MWCNT-CHIT-GLDH-NAD+-MB-SPCE biosensor stability 
study. 
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Appendix Table 1) t-Test to determine the significance between the standard addition 
results for post 24hr 1mM and 5mM paracetamol doses.  
 
 
t-Test: Two-Sample Assuming Equal Variances
Variable 1 Variable 2
Mean 52.07 93.30279
Variance 51.1923 295.1111
Observations 3 3
Pooled Variance 173.1517
Hypothesized Mean Difference 0
df 4
t Stat -3.83773
P(T<=t) one-tail 0.009248
t Critical one-tail 2.131847
P(T<=t) two-tail 0.018495
t Critical two-tail 2.776445
